Query String: IFN-gamma retinoid
- retinoid-related orphan receptor-gamma
- retinoid-related orphan receptor-gamma (rorgt)
- retinoid x receptor gamma/retinoic acid receptor alpha
- retinoid receptor
- retinoid x receptor
- rpe65 retinoid isomerase
- retinoid x receptor alpha
- retinoid-related orphan receptor-alpha
- retinoid-related orphan receptor-beta
- retinoid x receptor alpha (f313i/l436f)
- retinoic acid receptor alpha/retinoid x receptor alpha
- peroxisome proliferator-activated receptor gamma (ppar gamma)
- gamma secretase
- gamma-cystathionase
- gamma-secretase
- ppar-gamma
- rar-gamma
- gamma-aminobutyric acid receptor subunit alpha-1/gamma-2
- dag kinase gamma
- g gamma-i
- gamma hydroxybutyric, ghb
- gamma-carbonic anhydrase
- gamma-glutamylcysteine synthetase
- gmp-pde gamma
- p38 delta/gamma
- ppar alpha/gamma
- gamma-aminobutyric acid receptor subunit alpha-1/beta-3/gamma-2
- gamma-aminobutyric acid receptor subunit alpha-2/beta-2/gamma-1
- gamma-aminobutyric acid receptor subunit alpha-2/beta-3/gamma-2
- gamma-aminobutyric acid receptor subunit alpha-3/beta-3/gamma-2
- gamma-aminobutyric acid receptor subunit alpha-4/beta-2/gamma-2
- gamma-aminobutyric acid receptor subunit alpha-4/beta-3/gamma-2
- gamma-aminobutyric acid receptor subunit alpha-5/beta-2/gamma-1
- gamma-aminobutyric acid receptor subunit alpha-5/beta-2/gamma-2
- gamma-aminobutyric acid receptor subunit alpha-6/beta-3/gamma-2
- akap-7 isoform gamma
- dna-pk/ p110-gamma
- interferon gamma receptor 1
- interferon gamma-inducing factor
- nuclear receptor ror-gamma
- phospholipase c, gamma 1
- phospholipase c-gamma-1
- phospholipase c-gamma-2
- pi3k-alpha/ p110-gamma
- retinoic acid receptor gamma
- retinoic acid receptor, gamma
- gamma-secretase subunit aph-1a/gamma-secretase subunit aph-1b/gamma-secretase subunit pen-2/nicastrin/presenilin-1/presenilin-2
- 14-3-3 protein gamma
- cam kinase ii delta/gamma
- casein kinase i gamma 2
- gaba receptor gamma-1 subunit
- gamma carbonic anhydrase family protein
- gamma-amino-n-butyrate transaminase
- gamma-secretase subunit pen-2
- nuclear receptor ror-gamma (rorc)
- peroxisome proliferator-activated receptor gamma
- phosphoinositide 3-kinase (pi3k), gamma
- phosphoinositide 3-kinase-c2-gamma
- protein-glutamine gamma-glutamyltransferase 2
- protein-glutamine gamma-glutamyltransferase 6
- protein-glutamine gamma-glutamyltransferase e
- protein-glutamine gamma-glutamyltransferase k
- protein-glutamine gamma-glutamyltransferase z
- protein-glutamine gamma-glutamyltransferase, liver
- retinoic acid receptor rxr-gamma
- retinoic acid receptors gamma / alpha
- urease subunit alpha/beta/gamma
- gamma-secretase subunit aph-1a/gamma-secretase subunit pen-2/nicastrin [34-709]/presenilin-1
- acetylcholine receptor; alpha1/beta1/delta/gamma
- casein kinase i gamma 1 isoform
- nuclear receptor ror-gamma [238-497]
- nuclear receptor ror-gamma [258-518]
- peroxisome proliferator-activated receptor gamma (pparg)
- receptor-type tyrosine-protein phosphatase gamma
- retinoic acid receptor gamma [183-417]
- retinoic acid receptor rxr-alpha/gamma
- serine/threonine-protein kinase mrck gamma
- urease subunit alpha [f36l]/beta/gamma
- gamma-aminobutyric acid receptor subunit alpha-1 [g200c]/beta-2 [26-512]/gamma-2 [40-467]
- gamma-aminobutyric acid receptor subunit alpha-1 [s205c]/beta-2 [26-512]/gamma-2 [40-467]
- gamma-aminobutyric acid receptor subunit alpha-1 [t206c]/beta-2 [26-512]/gamma-2 [40-467]
- gamma-aminobutyric acid receptor subunit alpha-1 [v202c]/beta-2 [26-512]/gamma-2 [40-467]
- gamma-aminobutyric acid receptor subunit alpha-1 [v211c]/beta-2 [26-512]/gamma-2 [40-467]
- gamma-aminobutyric acid receptor subunit alpha-1 [28-456]/beta-2 [26-512]/gamma-2 [40-467]
- gamma-aminobutyric acid receptor subunit alpha-1 [28-456]/beta-3 [26-473]/gamma-2 [40-467]
- gamma-aminobutyric acid receptor subunit alpha-2 [29-451]/beta-2 [26-512]/gamma-2 [40-467]
- gamma-aminobutyric acid receptor subunit alpha-2 [29-451]/beta-3 [26-473]/gamma-2 [40-467]
- gamma-aminobutyric acid receptor subunit alpha-3 [29-492]/beta-3 [26-473]/gamma-2 [40-467]
- gamma-aminobutyric acid receptor subunit alpha-4 [36-554]/beta-2 [26-512]/gamma-2 [40-467]
- gamma-aminobutyric acid receptor subunit alpha-6 [20-453]/beta-2 [26-512]/gamma-2 [40-467]
- gamma-aminobutyric acid receptor subunit alpha-6 [20-453]/beta-3 [26-473]/gamma-2 [40-467]
- 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1
- 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1
- acetylcholine receptor subunit alpha/beta/delta/gamma
- amp-activated protein kinase, gamma-1 subunit
- camp-dependent protein kinase catalytic subunit gamma
- eukaryotic translation initiation factor 4 gamma 1
- gamma-aminobutyric acid receptor subunit alpha (gabaa)
- gamma-aminobutyric acid receptor subunit alpha-1
- gamma-aminobutyric acid receptor subunit alpha-3
- gamma-aminobutyric acid receptor subunit beta-1
- gamma-aminobutyric acid receptor subunit rho-1
- gamma-aminobutyric acid receptor subunit rho-2
- gamma-aminobutyric acid receptor subunit rho-3
- mitogen-activated protein kinase 12 (p38 gamma)
- nicotinic acetylcholine receptor alpha1/beta1/gamma/delta
- nuclear receptor ror-gamma (aa 262-507)
- nuclear receptor ror-gamma [258-518,y502f]
- peroxisome proliferator-activated receptor alpha/delta/gamma
- peroxisome proliferator-activated receptor gamma [205-505]
- voltage-dependent calcium channel gamma-1 subunit
- gamma-aminobutyric acid receptor subunit alpha-1 [28-456]/beta-2 [26-512]/gamma-2 [40-467,a118c]
- gamma-aminobutyric acid receptor subunit alpha-1 [28-456]/beta-2 [26-512]/gamma-2 [40-467,m169c]
- gamma-aminobutyric acid receptor subunit alpha-1 [28-456]/beta-2 [26-512]/gamma-2 [40-467,t120c]
- acetylcholine receptor protein alpha/beta/delta/gamma chain
- gabaa receptor, alpha-3, beta-2, gamma-2
- gabaa receptor, alpha-4, beta-3, gamma-2
- gabaa receptor, alpha-5, beta-2, gamma-2
- gabaa receptor, alpha-5, beta-3, gamma-2
- gabaa subunit alpha-1, beta-2, gamma-2
- gamma-aminobutyric acid receptor subunit alpha-2 (gabra2)
- gamma-aminobutyric acid receptor subunit alpha-2/delta
- phosphatidylinositol 3-kinase c2 domain-containing subunit gamma
- phosphatidylinositol 4-phosphate 5-kinase type i gamma
- phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
- pi(5)p 4-kinase type ii gamma
- retinoic acid-related nuclear receptor gamma t (rorgammat)
- serine/threonine-protein phosphatase pp1-gamma catalytic subunit
- gamma-aminobutyric acid receptor subunit alpha-1 [28-456]/beta-2 [26-512]/gamma-2 [40-200],p14867[176-456]
- 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [663-759]
- ampk complex 1 (alpha-1,beta-1,gamma-1)
- ampk complex 7 (alpha-2,beta-1,gamma-1)
- gaba a receptor alpha-1/beta-1/gamma-2
- gaba a receptor alpha-2/beta-2/gamma-2
- gaba a receptor alpha-3/beta-2/gamma-2
- gaba a receptor alpha-4/beta-3/gamma-2
- gaba a receptor alpha-5/beta-3/gamma-2
- gaba a receptor alpha-6/beta-2/gamma-2
- gaba receptor alpha-1/beta-1/gamma-2 subunit
- gaba receptor alpha-1/beta-2/gamma-2 subunit
- gaba receptor alpha-2/beta-2/gamma-2 subunit
- gaba receptor alpha-2/beta-3/gamma-2 subunit
- gaba receptor alpha-3/beta-3/gamma-2 subunit
- gaba receptor alpha-4/beta-3/gamma-2 subunit
- gaba receptor alpha-5/beta-3/gamma-2 subunit
- gaba receptor alpha-6/beta-2/gamma-2 subunit
- gaba-a receptor; alpha-1/beta-3/gamma-2
- gaba-a receptor; alpha-5/beta-3/gamma-2
- gaba-a receptor; alpha-6/beta-3/gamma-2
- gamma-aminobutyric acid receptor (gaba(a)) subunit alpha-4
- gamma-aminobutyric acid receptor subunit alpha-1/beta-1
- gamma-aminobutyric acid receptor subunit alpha-1/beta-2
- gamma-aminobutyric acid receptor subunit alpha-1/beta-3
- gamma-aminobutyric acid receptor subunit alpha-4/beta-3
- gamma-aminobutyric acid receptor subunit alpha-4/beta3/delta
- gamma-aminobutyric acid receptor subunit alpha-6/beta-2
- gamma-aminobutyric acid receptor subunit alpha-6/beta-3
- gamma-aminobutyric acid receptor subunit beta-1/beta-2
- gamma-aminobutyric acid type b receptor subunit 1/2
- peroxisome proliferator-activated receptor gamma/nuclear receptor corepressor 2
- phosphatidylinositol 4,5-biphosphate 3-kinase catalytic subunit gamma (pik3cg)
- phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
- phosphorylase b kinase gamma catalytic chain, liver/testis isoform
- protein-glutamine gamma-glutamyltransferase 2/tyrosine-protein kinase jak3
- retinoic acid-related nuclear receptor gamma t (ror t)
- serine/threonine-protein phosphatase 2b catalytic subunit gamma isoform
- amp-activated protein kinase alpha-2/beta-2/gamma-2
- calcium/calmodulin-dependent protein kinase type ii subunit gamma (camkllg)
- gabaa receptor mutant, alpha-1 (a160c), beta-2, gamma-2
- gabaa receptor mutant, alpha-1 (d97c), beta-2, gamma-2
- gabaa receptor mutant, alpha-1 (f99c), beta-2, gamma-2
- gabaa receptor mutant, alpha-1 (g157c), beta-2, gamma-2
- gabaa receptor mutant, alpha-1 (s204c), beta-2, gamma-2
- gabaa receptor mutant, alpha-1 (t162c), beta-2, gamma-2
- gabaa receptor mutant, alpha-1 (y209c), beta-2, gamma-2
- gabaa receptor mutant, alpha-1, beta-2, gamma-2 (d56c)
- gabaa receptor mutant, alpha-1, beta-2, gamma-2 (f77c)
- gabaa receptor mutant, alpha-1, beta-2, gamma-2 (l140c)
- gabaa receptor mutant, alpha-1, beta-2, gamma-2 (r132c)
- gabaa receptor mutant, alpha-1, beta-2, gamma-2 (r144c)
- gabaa receptor mutant, alpha-1, beta-2, gamma-2 (r185c)
- gabaa receptor mutant, alpha-1, beta-2, gamma-2 (r194c)
- gabaa receptor mutant, alpha-1, beta-2, gamma-2 (t126c)
- gabaa receptor mutant, alpha-1, beta-2, gamma-2 (t142c)
- gamma-aminobutyric acid receptor subunit alpha-1/beta-2/delta
- gamma-aminobutyric acid receptor subunit alpha-1/beta-3/delta
- gamma-aminobutyric acid receptor subunit alpha-4/beta-1/delta
- gamma-aminobutyric acid receptor subunit alpha-4/beta-2/delta
- gamma-aminobutyric acid receptor subunit alpha-4/beta-3/delta
- gamma-aminobutyric acid receptor subunit alpha-6/beta-2/delta
- gamma-aminobutyric acid receptor subunit alpha-6/beta-3/delta
- peroxisome proliferator-activated receptor gamma/retinoic acid receptor rxr-alpha
- phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta/gamma isoform
- phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform
Guanosine 5 -(gamma-S)triphosphate BDBM35866 GTP-gamma-S gamma-Thio-GTP
3-(gamma,gamma-dimethylallyl)resveratrol BDBM50269596 CHEMBL457145
BDBM50269598 3-(gamma,gamma-dimethylpropenyl)moracinM CHEMBL463125
BDBM50269599 5-(gamma,gamma-dimethylallyl)-oxyresveratrol CHEMBL463126
gamma-cyclodextrin BDBM36126
alpha-methyl-gamma,gamma-diphenylallenecarboxylic acid ethyl ester CHEMBL443611 BDBM50292631
CHEMBL558092 BDBM50294101 N1-Benzylamine-N3-(gamma,gamma-dimethylallyl)guanidine Bis-(trifluoroacetate)
TMe-gamma-cyclodextrin BDBM36248
gamma-methyl-APB BDBM82005
4-[N3-gamma,gamma-Dimethyallyl)guanidino]-1-guanidino-butane bis(trifluoroacetate) BDBM50294103 CHEMBL549342
BDBM50205417 CHEMBL220200 UTP-gamma-S
BDBM50250088 [gamma-lactam4,5]PACAP27 CHEMBL524528
BDBM50250089 CHEMBL501268 [gamma-lactam4,5]PACAP38
CHEMBL514745 3'-[gamma-hydroxymethyl-(E)-gamma-methylallyl]-2,4,2',4'-tetrahydroxychalcone 11'-O-coumarate BDBM50250979
N1-[3'-Aminopropyl)-3-aminopropyl]-N3-(gamma,gamma-dimethylallyl)-guanidine bis(trifluoroacetate) CHEMBL553638 BDBM50294102
Cycloartenol Trans-Ferulate BDBM50483936 Gamma Oryzanol 3-O-Ferulylcycloartenol Cycloartenyl Ferulate Cycloartenol Ferulate Gamma-Oryzanol
KWELL Gammallin Gexane BDBM50410525 LINDANE HEXICIDE Gamma Benzene Hydrochloride Gammaxene GAMENE HEXACHLORANE BENZENE HEXACHLORIDE, GAMMA
BDBM50275048 CHEMBL446976 2-octyl gamma-bromoacetoacetate
BDBM92992 L-glutamate gamma-methyl ester
CHEMBL1098291 BDBM50531188 Carnosic Acid Gamma-Lactone
CHEMBL244883 BDBM50199731 methotrexate gamma-hydroxamic acid
CHEMBL85937 BDBM50104419 Glutamyl-gamma-boronate analogue
CHEMBL87796 Glutamyl-gamma-boronate analogue BDBM50104413
NSC_440317 BDBM86479 CAS_440317 ATP,Gamma S
alpha, gamma-diketo acid, 1 BDBM33409
(2S)-6-(gamma,gamma-dimethylallyl)-3',4'-dimethoxy-6'',6''-dimethylpyran[2'',3'':7,8]flavanone BDBM50241693 CHEMBL516860
CHEMBL267603 BDBM50199734 folate gamma-L-phenylalaninehydroxamic acid
US9328123, Rotenone B BDBM224807 Gamma-irradiated rotenone
methotrexate gamma-L-phenylalaninehydroxamic acid CHEMBL396296 BDBM50199733
CHEMBL464609 BDBM50241692 (2S)-6-(gamma,gamma-dimethylallyl)-5,4'-dihydroxy-3'-methoxy-6'',6''-dimethylpyran[2'',3'':7,8]flavanone
4-Hydroxyvaleric acid lactone dihydro-5-methyl-2(3H)-furanone gamma-valerolactone 4-Valerolactone gamma-Pentanolactone 4-Methyl-4-hydroxybutanoic acid lactone CHEMBL195593 5-methyldihydrofuran-2(3H)-one BDBM50168010 4-Pentanolide gamma-Pentalactone 4-Methyl-gamma-butyrolactone 4-Hydroxypentanoic acid lactone
(2S)-6-(gamma,gamma-dimethylallyl)-5-3'-dihydroxy-4'-methoxy-6'',6''dimethylpyran[2'',3''7,8]flavanone CHEMBL451703 BDBM50241688
CHEMBL455606 BDBM50241687 (2S)-6-(gamma,gamma-dimethylallyl)-5-hydroxy-3',4'-dimethoxy-6'',6''-dimethylpyran[2'',3'':7,8]flavanone
CHEMBL494570 1-(6-aminohexyl)-3-(3-methylbut-2-enyl)guanidine BDBM50294113 N-(gamma,gamma-Dimethylallyl)-N-(6-aminohexyl)-guanidine
N-(gamma,gamma-Dimethylallyl)-N-(5-aminopentyl)-guanidine BDBM50294112 1-(5-aminopentyl)-3-(3-methylbut-2-enyl)guanidine CHEMBL495424
CHEMBL1398 Alpha-Phenyl-Gamma-Butyrolactone alpha-phenylbutyrolactone BDBM50180937
CHEMBL388879 methotrexate gamma-L-proline-hydroxamic acid BDBM50199735
Gamma2-MSH GAMMA-MSH BDBM82413 CAS_72711-43-4
GHB BDBM50023575 4-hydroxybutanoic acid 4-hydroxybutyric acid 4-hydroxy-butyric acid CHEMBL1342 Xyrem gamma-hydroxybutyric acid Gamma Hydroxybutyric Acid
4,4-difluoro-N(gamma)-hydroxy-L-arginine CHEMBL476417 BDBM50266728
2-Nitrooxy-N-[3-(1,2,3,4-tetrahydro-acridin-9-ylamino)-propyl]-acetamide 9-[N-gamma-(2'-(nitrooxy)acetyl)-gamma-aminopropylamino]-1,2,3,4-tetrahydroacridine CHEMBL269865 BDBM50233367
BDBM50270551 P1,P4-di(uridine 5'-)beta,gamma-difluoromethylenetetraphosphate CHEMBL502712
CAS_57659-38-8 Acetylenic GABA-7 BDBM81477 GAMMA-ACETYLENIC GABA
P1,P4-di(uridine 5'-)beta,gamma-dichloromethlyenetetraphosphate BDBM50270552 CHEMBL476021
adenosine 5'-O-(3-thiotriphosphate) ATP{gamma}S BDBM36312
- Musicki, B; Bouix-Peter, C; Ouvry, G; Thoreau, E Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (RORγ(T)) US Patent US10457637 (2019)
- Dawson, MI; Jong, L; Hobbs, PD; Cameron, JF; Chao, WR; Pfahl, M; Lee, MO; Shroot, B; Pfahl, M Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. J Med Chem 38: 3368-83 (1995)
- Cavasotto, CN; Liu, G; James, SY; Hobbs, PD; Peterson, VJ; Bhattacharya, AA; Kolluri, SK; Zhang, XK; Leid, M; Abagyan, R; Liddington, RC; Dawson, MI Determinants of retinoid X receptor transcriptional antagonism. J Med Chem 47: 4360-72 (2004)
- Jong, L; Lehmann, JM; Hobbs, PD; Harlev, E; Huffman, JC; Pfahl, M; Dawson, MI Conformational effects on retinoid receptor selectivity. 1. Effect of 9-double bond geometry on retinoid X receptor activity. J Med Chem 36: 2605-13 (1993)
- Farmer, LJ; Marron, KS; Canan Koch, SS; Hwang, CK; Kallel, EA; Zhi, L; Nadzan, AM; Robertson, DW; Bennani, YL Aza-retinoids as novel retinoid X receptor-specific agonists. Bioorg Med Chem Lett 16: 2352-6 (2006)
- Yamada, S; Ohsawa, F; Fujii, S; Shinozaki, R; Makishima, M; Naitou, H; Enomoto, S; Tai, A; Kakuta, H Fluorescent retinoid X receptor ligands for fluorescence polarization assay. Bioorg Med Chem Lett 20: 5143-6 (2010)
- Canan Koch, SS; Dardashti, LJ; Hebert, JJ; White, SK; Croston, GE; Flatten, KS; Heyman, RA; Nadzan, AM Identification of the first retinoid X, receptor homodimer antagonist. J Med Chem 39: 3229-34 (1996)
- Beard, RL; Klein, ES; Standeven, AM; Escobar, M; Chandraratna, RA Phenylcyclohexene and phenylcyclohexadiene substituted compounds having retinoid antagonist activity. Bioorg Med Chem Lett 11: 765-8 (2001)
- Haffner, CD; Lenhard, JM; Miller, AB; McDougald, DL; Dwornik, K; Ittoop, OR; Gampe, RT; Xu, HE; Blanchard, S; Montana, VG; Consler, TG; Bledsoe, RK; Ayscue, A; Croom, D Structure-based design of potent retinoid X receptor alpha agonists. J Med Chem 47: 2010-29 (2004)
- Chandraratna, RA; Gillett, SJ; Song, TK; Attard, J; Vuligonda, S; Garst, ME; Arefieg, T; Gil, DW; Wheeler, L Synthesis and pharmacological activity of conformationally restricted, acetylenic retinoid analogs Bioorg Med Chem Lett 5: 523-527 (1995)
- Alvarez, S; Alvarez, R; Khanwalkar, H; Germain, P; Lemaire, G; Rodríguez-Barrios, F; Gronemeyer, H; de Lera, AR Retinoid receptor subtype-selective modulators through synthetic modifications of RARgamma agonists. Bioorg Med Chem 17: 4345-59 (2009)
- Farmer, LJ; Jeong, S; Kallel, EA; Koch, SS; Croston, GE; Flatten, KS; Heyman, RA; Nadzan, AM Synthesis and structure-activity relationships of potent retinoid X receptor ligands Bioorg Med Chem Lett 7: 2393-2398 (1997)
- Robarge, MJ; Repa, JJ; Hanson, KK; Seth, S; Clagett-Dame, M; Abou-Issa, H; Jr., RC N-linked analogs of retinoid O-glucuronides: potential cancer chemopreventive/chemotherapeutic agents Bioorg Med Chem Lett 4: 2117-2122 (1994)
- Boehm, MF; Zhang, L; Badea, BA; White, SK; Mais, DE; Berger, E; Suto, CM; Goldman, ME; Heyman, RA Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. J Med Chem 37: 2930-41 (1994)
- Pollinger, J; Gellrich, L; Schierle, S; Kilu, W; Schmidt, J; Kalinowsky, L; Ohrndorf, J; Kaiser, A; Heering, J; Proschak, E; Merk, D Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation. J Med Chem 62: 2112-2126 (2019)
- Wang, X; Xu, W; Wang, Z; Yu, Q; Yuan, L; Liu, Y; Sang, J; Li, W; Zhu, S; Jiang, W; Li, Z; Zhang, W; Dang, Y Sokotrasterol Sulfate Suppresses IFN-γ-Induced PD-L1 Expression by Inhibiting JAK Activity. J Nat Prod 87: 713-721 (2024)
- Merk, D; Grisoni, F; Friedrich, L; Gelzinyte, E; Schneider, G Computer-Assisted Discovery of Retinoid X Receptor Modulating Natural Products and Isofunctional Mimetics. J Med Chem 61: 5442-5447 (2018)
- Kotani, H; Tanabe, H; Mizukami, H; Makishima, M; Inoue, M Identification of a naturally occurring rexinoid, honokiol, that activates the retinoid X receptor. J Nat Prod 73: 1332-6 (2010)
- Kobayashi, T; Furusawa, Y; Yamada, S; Akehi, M; Takenaka, F; Sasaki, T; Akahoshi, A; Hanada, T; Matsuura, E; Hirano, H; Tai, A; Kakuta, H Positron emission tomography to elucidate pharmacokinetic differences of regioisomeric retinoid x receptor agonists. ACS Med Chem Lett 6: 334-8 (2015)
- Vuligonda, V; Garst, ME; Chandraratna, RA Stereoselective synthesis and receptor activity of conformationally defined retinoid X receptor selective ligands. Bioorg Med Chem Lett 9: 589-94 (1999)
- Beard, RL; Gil, DW; Marler, DK; Henry, E; Colon, DF; Gillett, SJ; Arefieg, T; Breen, TS; Krauss, H; Davies, PJ; Chandraratna, RA Structural basis for the differential RXR & RAR activity of stilbene retinoid analogs Bioorg Med Chem Lett 4: 1447-1452 (1994)
- Farmer, LJ; Zhi, L; Jeong, S; Kallel, EA; Croston, G; Flatten, KS; Heyman, RA; Nadzan, AM Synthesis and structure-activity relationships of potent conformationally restricted retinoid X receptor ligands Bioorg Med Chem Lett 7: 2747-2752 (1997)
- Heitel, P; Gellrich, L; Kalinowsky, L; Heering, J; Kaiser, A; Ohrndorf, J; Proschak, E; Merk, D Computer-Assisted Discovery and Structural Optimization of a Novel Retinoid X Receptor Agonist Chemotype. ACS Med Chem Lett 10: 203-208 (2019)
- Vuligonda, V; Thacher, SM; Chandraratna, RA Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes. J Med Chem 44: 2298-303 (2001)
- Wang, Y; Connors, R; Fan, P; Wang, X; Wang, Z; Liu, J; Kayser, F; Medina, JC; Johnstone, S; Xu, H; Thibault, S; Walker, N; Conn, M; Zhang, Y; Liu, Q; Grillo, MP; Motani, A; Coward, P; Wang, Z Structure-assisted discovery of the first non-retinoid ligands for Retinol-Binding Protein 4. Bioorg Med Chem Lett 24: 2885-91 (2014)
- Beard, RL; Chandraratna, RA; Colon, DF; Gillett, SJ; Henry, E; Marler, DK; Song, T; Denys, L; Garst, ME; Arefieg, T Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids. J Med Chem 38: 2820-9 (1995)
- Wu, W; Burnett, DA Gamma secretase inhibitors US Patent US9226927 (2016)
- Rotella, DP Gamma secretase modulators. ACS Med Chem Lett 4: (2013)
- MOHAN, R; NUSS, J; HARRIS, J ROR-GAMMA MODULATORS US Patent US20230277527 (2023)
- Pollinger, J; Schierle, S; Gellrich, L; Ohrndorf, J; Kaiser, A; Heitel, P; Chaikuad, A; Knapp, S; Merk, D A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences. ACS Med Chem Lett 10: 1346-1352 (2019)
- Sundén, H; Schäfer, A; Scheepstra, M; Leysen, S; Malo, M; Ma, JN; Burstein, ES; Ottmann, C; Brunsveld, L; Olsson, R Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor-Nuclear Receptor Related 1 Protein Dimer Activation. J Med Chem 59: 1232-8 (2016)
- Yamada, S; Kawasaki, M; Fujihara, M; Watanabe, M; Takamura, Y; Takioku, M; Nishioka, H; Takeuchi, Y; Makishima, M; Motoyama, T; Ito, S; Tokiwa, H; Nakano, S; Kakuta, H Competitive Binding Assay with an Umbelliferone-Based Fluorescent Rexinoid for Retinoid X Receptor Ligand Screening. J Med Chem 62: 8809-8818 (2019)
- Yukawa-Takamatsu, K; Wang, Y; Watanabe, M; Takamura, Y; Fujihara, M; Nakamura-Nakayama, M; Yamada, S; Kikuzawa, S; Makishima, M; Kawasaki, M; Ito, S; Nakano, S; Kakuta, H Convenient Retinoid X Receptor Binding Assay Based on Fluorescence Change of the Antagonist NEt-C343. J Med Chem 64: 861-870 (2021)
- Beard, RL; Colon, DF; Klein, ES; Vorse, KA; Chandraratna, RA Differential RXR & RAR activity of stilbene retinoid analogs bearing thiazole and imidazole carboxylic acids Bioorg Med Chem Lett 5: 2729-2734 (1995)
- Sun, W; Carroll, PJ; Soprano, DR; Canney, DJ Identification of a chromone-based retinoid containing a polyolefinic side chain via facile synthetic routes. Bioorg Med Chem Lett 19: 4339-42 (2009)
- Umemiya, H; Fukasawa, H; Ebisawa, M; Eyrolles, L; Kawachi, E; Eisenmann, G; Gronemeyer, H; Hashimoto, Y; Shudo, K; Kagechika, H Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers. J Med Chem 40: 4222-34 (1998)
- Boehm, MF; Zhang, L; Zhi, L; McClurg, MR; Berger, E; Wagoner, M; Mais, DE; Suto, CM; Davies, JA; Heyman, RA Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J Med Chem 38: 3146-55 (1995)
- Lagu, B; Lebedev, R; Pio, B; Yang, M; Pelton, PD Dihydro-[1H]-quinolin-2-ones as retinoid X receptor (RXR) agonists for potential treatment of dyslipidemia. Bioorg Med Chem Lett 17: 3491-6 (2007)
- Beard, RL; Colon, DF; Song, TK; Davies, PJ; Kochhar, DM; Chandraratna, RA Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid. J Med Chem 39: 3556-63 (1996)
- Moslin, RM; Weinstein, DS; Wrobleski, ST Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses US Patent US11021475 (2021)
- Discovery of an efficacious KDM5B PROTAC degrader GT-653 up-regulating IFN response genes in prostate cancer.
- Mohan, R; Nuss, J; Harris, J; Yuan, S Spirocyclic ROR-gamma modulators US Patent US11242350 (2022)
- Boerma, LJ; Xia, G; Qui, C; Cox, BD; Chalmers, MJ; Smith, CD; Lobo-Ruppert, S; Griffin, PR; Muccio, DD; Renfrow, MB Defining the communication between agonist and coactivator binding in the retinoid X receptor a ligand binding domain. J Biol Chem 289: 814-26 (2014)
- Canan Koch, SS; Dardashti, LJ; Cesario, RM; Croston, GE; Boehm, MF; Heyman, RA; Nadzan, AM Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells. J Med Chem 42: 742-50 (1999)
- Miura, K; Fujihara, M; Watanabe, M; Takamura, Y; Kawasaki, M; Nakano, S; Kakuta, H Direct evaluation of polarity of the ligand binding pocket in retinoid X receptor using a fluorescent solvatochromic agonist. Bioorg Med Chem Lett 96: (2023)
- Sparey, T; Beher, D; Best, J; Biba, M; Castro, JL; Clarke, E; Hannam, J; Harrison, T; Lewis, H; Madin, A; Shearman, M; Sohal, B; Tsou, N; Welch, C; Wrigley, J Cyclic sulfamide gamma-secretase inhibitors. Bioorg Med Chem Lett 15: 4212-6 (2005)
- Durón, SG; Chapman, J; Sydserff, SG; Rao, SG; Stein, G Cystathionine-gamma-lyase (CSE) inhibitors US Patent US10227314 (2019)
- Claremon, DA; Dillard, LW; Dong, C; Fan, Y; Jia, L; Liu, Z; Lotesta, SD; Marcus, A; Singh, SB; Tice, CM; Yuan, J; Zhao, W; Zheng, Y; Zhuang, L Dihydropyrrolopyridine inhibitors of ROR-gamma US Patent US9624217 (2017)
- Caldwell, JP; Bennett, CE; McCracken, TM; Mazzola, RD; Bara, T; Buevich, A; Burnett, DA; Chu, I; Cohen-Williams, M; Josein, H; Hyde, L; Lee, J; McKittrick, B; Song, L; Terracina, G; Voigt, J; Zhang, L; Zhu, Z Iminoheterocycles as gamma-secretase modulators. Bioorg Med Chem Lett 20: 5380-4 (2010)
- Claremon, DA; Dillard, LW; Dong, C; Fan, Y; Jia, L; Lotesta, SD; Marcus, A; Singh, SB; Tice, CM; Yuan, J; Zhao, W; Zheng, Y; Zhuang, L Isoindoline inhibitors of ROR-gamma US Patent US9845308 (2017)
- Hall, A; Elliott, RL; Giblin, GM; Hussain, I; Musgrave, J; Naylor, A; Sasse, R; Smith, B Piperidine-derived gamma-secretase modulators. Bioorg Med Chem Lett 20: 1306-11 (2010)
- Tsukamoto, T; Kitazume, T; McGuire, JJ; Coward, JK Synthesis and biological evaluation of DL-4,4-difluoroglutamic acid and DL-gamma,gamma-difluoromethotrexate. J Med Chem 39: 66-72 (1996)
- Mehndiratta, S; Lin, MH; Wu, YW; Chen, CH; Wu, TY; Chuang, KH; Chao, MW; Chen, YY; Pan, SL; Chen, MC; Liou, JP N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression. Eur J Med Chem 185: (2020)
- Desphande, A; Xia, G; Boerma, LJ; Vines, KK; Atigadda, VR; Lobo-Ruppert, S; Grubbs, CJ; Moeinpour, FL; Smith, CD; Christov, K; Brouillette, WJ; Muccio, DD Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention. Bioorg Med Chem 22: 178-85 (2013)
- Velter, AI; Bischoff, FP; Berthelot, D; De Cleyn, M; Oehlrich, D; Jaroskova, L; Macdonald, G; Minne, G; Pieters, S; Rombouts, F; Van Brandt, S; Van Roosbroeck, Y; Surkyn, M; Trabanco, AA; Tresadern, G; Wu, T; Borghys, H; Mercken, M; Masungi, C; Gijsen, H Anilinotriazoles as potent gamma secretase modulators. Bioorg Med Chem Lett 24: 5805-13 (2014)
- Abou-Gharbia, M; Patel, UR; Webb, MB; Moyer, JA; Andree, TH; Muth, EA Antipsychotic activity of substituted gamma-carbolines. J Med Chem 30: 1818-23 (1987)
- Castro Palomino Laria, J; Camacho Gómez, J; Rodríguez Iglesias, R Benzamide derivatives as PPAR-gamma modulators US Patent US11267808 (2022)
- Prasad, CV; Wallace, OB; Noonan, JW; Sloan, CP; Lau, W; Vig, S; Parker, MF; Smith, DW; Hansel, SB; Polson, CT; Barten, DM; Felsenstein, KM; Roberts, SB Hydroxytriamides as potent gamma-secretase inhibitors. Bioorg Med Chem Lett 14: 1917-21 (2004)
- Mogemark, M; Pemberton, N; Petersen, J; Perry, M; Karabelas, K; Zlatoidsky, P; Cox, R; Tyrchan, C Inhibitors of phosphatidylinositol 3-kinase gamma US Patent US10858355 (2020)
- Sharma, R; Sahu, B; Mali, SV; Singh, D; Kumar, PB; Dawange, M; Mistry, H ROR-gamma modulators and uses thereof US Patent US11084784 (2021)
- Pissarnitski, D; Zhao, Z Spirocyclic sulfones as gamma secretase inhibitors US Patent US9464103 (2016)
- Mohan, R; Nuss, J; Harris, J Substituted piperazines as ROR-gamma modulators US Patent US10905687 (2021)
- Asberom, T; Bara, TA; Clader, JW; Greenlee, WJ; Guzik, HS; Josien, HB; Li, W; Parker, EM; Pissarnitski, DA; Song, L; Zhang, L; Zhao, Z Tetrahydroquinoline sulfonamides as gamma-secretase inhibitors. Bioorg Med Chem Lett 17: 205-7 (2007)
- Marcoux, D; Beaudoin Bertrand, M; Dhar, TG; Yang, MG; Xiao, Z; Xiao, H; Zhu, Y; Weigelt, CA; Batt, DG Tricyclic sulfones as ROR gamma modulators US Patent US10435369 (2019)
- Wu, H; Zink, N; Carter, LP; Mehta, AK; Hernandez, RJ; Ticku, MK; Lamb, R; France, CP; Coop, A A tertiary alcohol analog of gamma-hydroxybutyric acid as a specific gamma-hydroxybutyric acid receptor ligand. J Pharmacol Exp Ther 305: 675-9 (2003)
- Scholze, P; Ebert, V; Sieghart, W Affinity of various ligands for GABAA receptors containing alpha 4 beta 3 gamma 2, alpha 4 gamma 2, or alpha 1 beta 3 gamma 2 subunits. Eur J Pharmacol 304: 155-62 (1996)
- Gege, C; Schlüter, T; Hoffmann, T Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORß and ROR¿t. Bioorg Med Chem Lett 24: 5265-7 (2014)
- Parker, MF; Bronson, JJ; Barten, DM; Corsa, JA; Du, W; Felsenstein, KM; Guss, VL; Izzarelli, D; Loo, A; McElhone, KE; Marcin, LR; Padmanabha, R; Pak, R; Polson, CT; Toyn, JH; Varma, S; Wang, J; Wong, V; Zheng, M; Roberts, SB Amino-caprolactam derivatives as gamma-secretase inhibitors. Bioorg Med Chem Lett 17: 5790-5 (2007)
- Zou, G; Combs, AP; Buesking, AW Aza-heteroaryl compounds as PI3K-gamma inhibitors US Patent US9586949 (2017)
- Claremon, DA; Dillard, LW; Fan, Y; Lotesta, SD; Singh, SB; Tice, CM; Zhao, W; Zhuang, L Benzimidazole derivatives as modulators of ROR-gamma US Patent US10829481 (2020)
- Lugar, III, CW; Morphy, JR; Richardson, TI; Rudyk, HC; Sapmaz, S; Stites, RE Compounds useful for inhibiting ROR-gamma-t US Patent US10603320 (2020)
- Harbert, CA; Plattner, JJ; Welch, WM; Weissman, A; Koe, BK Neuroleptic activity in 5-aryltetrahydro-gamma-carbolines. J Med Chem 23: 635-43 (1980)
- Rivkin, A; Ahearn, SP; Chichetti, SM; Hamblett, CL; Garcia, Y; Martinez, M; Hubbs, JL; Reutershan, MH; Daniels, MH; Siliphaivanh, P; Otte, KM; Li, C; Rosenau, A; Surdi, LM; Jung, J; Hughes, BL; Crispino, JL; Nikov, GN; Middleton, RE; Moxham, CM; Szewczak, AA; Shah, S; Moy, LY; Kenific, CM; Tanga, F; Cruz, JC; Andrade, P; Angagaw, MH; Shomer, NH; Miller, T; Munoz, B; Shearman, MS Purine derivatives as potent gamma-secretase modulators. Bioorg Med Chem Lett 20: 2279-82 (2010)
- Claremon, DA; Dillard, LW; Fan, Y; Lotesta, SD; Singh, SB; Tice, CM; Zhao, W; Zhuang, L Substituted indoles as modulators of ROR-gamma US Patent US10301261 (2019)
- Ujjinamatada, RK; Pandit, C Substituted tetrahydroquinolinone compounds as ROR gamma modulators US Patent US11229636 (2022)
- Chen, YL; Cherry, K; Corman, ML; Ebbinghaus, CF; Gamlath, CB; Liston, D; Martin, BA; Oborski, CE; Sahagan, BG Thiazole-diamides as potent gamma-secretase inhibitors. Bioorg Med Chem Lett 17: 5518-22 (2007)
- Watanabe, M; Fujihara, M; Motoyama, T; Kawasaki, M; Yamada, S; Takamura, Y; Ito, S; Makishima, M; Nakano, S; Kakuta, H Discovery of a "Gatekeeper" Antagonist that Blocks Entry Pathway to Retinoid X Receptors (RXRs) without Allosteric Ligand Inhibition in Permissive RXR Heterodimers. J Med Chem 64: 430-439 (2021)
- Cincinelli, R; Dallavalle, S; Nannei, R; Carella, S; De Zani, D; Merlini, L; Penco, S; Garattini, E; Giannini, G; Pisano, C; Vesci, L; Carminati, P; Zuco, V; Zanchi, C; Zunino, F Synthesis and structure-activity relationships of a new series of retinoid-related biphenyl-4-ylacrylic acids endowed with antiproliferative and proapoptotic activity. J Med Chem 48: 4931-46 (2005)
- Sakashita, H; Akahoshi, F; Yoshida, T; Kitajima, H; Hayashi, Y; Ishii, S; Takashina, Y; Tsutsumiuchi, R; Ono, S Lead optimization of [(S)-gamma-(arylamino)prolyl]thiazolidine focused on gamma-substituent: Indoline compounds as potent DPP-IV inhibitors. Bioorg Med Chem 15: 641-55 (2006)
- Birru, W; Fernley, RT; Graham, LD; Grusovin, J; Hill, RJ; Hofmann, A; Howell, L; James, PJ; Jarvis, KE; Johnson, WM; Jones, DA; Leitner, C; Liepa, AJ; Lovrecz, GO; Lu, L; Nearn, RH; O'Driscoll, BJ; Phan, T; Pollard, M; Turner, KA; Winkler, DA Synthesis, binding and bioactivity of gamma-methylene gamma-lactam ecdysone receptor ligands: advantages of QSAR models for flexible receptors. Bioorg Med Chem 18: 5647-60 (2010)
- Shaw, D; Best, J; Dinnell, K; Nadin, A; Shearman, M; Pattison, C; Peachey, J; Reilly, M; Williams, B; Wrigley, J; Harrison, T 3,4-Fused cyclohexyl sulfones as gamma-secretase inhibitors. Bioorg Med Chem Lett 16: 3073-7 (2006)
- Benzodiazepine derivatives as GABA A gamma 1 PAM
- Shi, J; Zuev, D; Xu, L; Lentz, KA; Grace, JE; Toyn, JH; Olson, RE; Macor, JE; Thompson, LA Design and optimization of tricyclic gamma-secretase modulators. Bioorg Med Chem Lett 26: 1498-502 (2016)
- Parks, DJ; Tomkinson, NC; Villeneuve, MS; Blanchard, SG; Willson, TM Differential activity of rosiglitazone enantiomers at PPAR gamma. Bioorg Med Chem Lett 8: 3657-8 (1999)
- Lu, H; Silverman, RB Fluorinated conformationally restricted gamma-aminobutyric acid aminotransferase inhibitors. J Med Chem 49: 7404-12 (2006)
- Stanton, MG; Hubbs, J; Sloman, D; Hamblett, C; Andrade, P; Angagaw, M; Bi, G; Black, RM; Crispino, J; Cruz, JC; Fan, E; Farris, G; Hughes, BL; Kenific, CM; Middleton, RE; Nikov, G; Sajonz, P; Shah, S; Shomer, N; Szewczak, AA; Tanga, F; Tudge, MT; Shearman, M; Munoz, B Fluorinated piperidine acetic acids as gamma-secretase modulators. Bioorg Med Chem Lett 20: 755-8 (2010)
- Xi, N; Arvedson, S; Eisenberg, S; Han, N; Handley, M; Huang, L; Huang, Q; Kiselyov, A; Liu, Q; Lu, Y; Nunez, G; Osslund, T; Powers, D; Tasker, AS; Wang, L; Xiang, T; Xu, S; Zhang, J; Zhu, J; Kendall, R; Dominguez, C N-Aryl-gamma-lactams as integrin alphavbeta3 antagonists. Bioorg Med Chem Lett 14: 2905-9 (2004)
- Sarges, R; Howard, HR; Donahue, KM; Welch, WM; Dominy, BW; Weissman, A; Koe, BK; Bordner, J Neuroleptic activity of chiral trans-hexahydro-gamma-carbolines. J Med Chem 29: 8-19 (1986)
- Peters, JU; Galley, G; Jacobsen, H; Czech, C; David-Pierson, P; Kitas, EA; Ozmen, L Novel orally active, dibenzazepinone-based gamma-secretase inhibitors. Bioorg Med Chem Lett 17: 5918-23 (2007)
- Li, P; Zheng, H; Davis, R; Mates, S; Vanover, K; Snyder, G Pharmaceutical compositions comprising heterocycle fused gamma carboline prodrugs US Patent US12173004 (2024)
- Rivkin, A; Ahearn, SP; Chichetti, SM; Kim, YR; Li, C; Rosenau, A; Kattar, SD; Jung, J; Shah, S; Hughes, BL; Crispino, JL; Middleton, RE; Szewczak, AA; Munoz, B; Shearman, MS Piperazinyl pyrimidine derivatives as potent gamma-secretase modulators. Bioorg Med Chem Lett 20: 1269-71 (2010)
- Sparks, RB; Shepard, S; Combs, AP; Buesking, AW; Shao, L; Wang, H; Falahatpisheh, N Pyridine and pyridimine compounds as PI3K-gamma inhibitors US Patent US11352340 (2022)
- da Silva, FM; dos Santos, JC; Campos, JL; Mafud, AC; Polikarpov, I; Figueira, AC; Nascimento, AS Structure-based identification of novel PPAR gamma ligands. Bioorg Med Chem Lett 23: 5795-802 (2013)
- Lowe, DB; Bifulco, N; Bullock, WH; Claus, T; Coish, P; Dai, M; Dela Cruz, FE; Dickson, D; Fan, D; Hoover-Litty, H; Li, T; Ma, X; Mannelly, G; Monahan, MK; Muegge, I; O'Connor, S; Rodriguez, M; Shelekhin, T; Stolle, A; Sweet, L; Wang, M; Wang, Y; Zhang, C; Zhang, HJ; Zhang, M; Zhao, K; Zhao, Q; Zhu, J; Zhu, L; Tsutsumi, M Substituted indanylacetic acids as PPAR-alpha-gamma activators. Bioorg Med Chem Lett 16: 297-301 (2005)
- Martres, P; Faucher, N; Laroze, A; Pineau, O; Fouchet, MH; Potvain, F; Grillot, D; Beneton, V The discovery of equipotent PPARalpha/gamma dual activators. Bioorg Med Chem Lett 18: 6251-4 (2008)
- Khairatkar-Joshi, N; Kulkarni, A; Shah, DM; Bhosale, VM; Lodhiya, BJ; Thiraviam, AM; Marathe, M; Hadambar, AA Treatment of respiratory disorders using ROR-gamma inhibitors US Patent US9855229 (2018)
- VISNICK, M; JIANG, X CYSTEINE-DEPENDENT INVERSE AGONISTS OF NUCLEAR RECEPTORS ROR-GAMMA/ROR-GAMMA-T AND METHODS OF TREATING DISEASES OR DISORDERS THEREWITH US Patent US20250059154 (2025)
- Mogensen, JP; Jeppesen, L; Bury, PS; Pettersson, I; Fleckner, J; Nehlin, J; Frederiksen, KS; Albrektsen, T; Din, N; Mortensen, SB; Svensson, LA; Wassermann, K; Wulff, EM; Ynddal, L; Sauerberg, P Design and synthesis of novel PPARalpha/gamma/delta triple activators using a known PPARalpha/gamma dual activator as structural template. Bioorg Med Chem Lett 13: 257-60 (2002)
- Vince, R; Brownell, J; Akella, LB Synthesis and activity of gamma-(L-gamma-azaglutamyl)-S-(p-bromobenzyl)-L-cysteinylglycine: a metabolically stable inhibitor of glyoxalase I. Bioorg Med Chem Lett 9: 853-6 (1999)
- Pissarnitski, DA; Asberom, T; Bara, TA; Buevich, AV; Clader, JW; Greenlee, WJ; Guzik, HS; Josien, HB; Li, W; McEwan, M; McKittrick, BA; Nechuta, TL; Parker, EM; Sinning, L; Smith, EM; Song, L; Vaccaro, HA; Voigt, JH; Zhang, L; Zhang, Q; Zhao, Z 2,6-Disubstituted N-arylsulfonyl piperidines as gamma-secretase inhibitors. Bioorg Med Chem Lett 17: 57-62 (2007)
- Bourguignon, JJ; Schoenfelder, A; Schmitt, M; Wermuth, CG; Hechler, V; Charlier, B; Maitre, M Analogues of gamma-hydroxybutyric acid. Synthesis and binding studies. J Med Chem 31: 893-7 (1988)
- Teall, M; Oakley, P; Harrison, T; Shaw, D; Kay, E; Elliott, J; Gerhard, U; Castro, JL; Shearman, M; Ball, RG; Tsou, NN Aryl sulfones: a new class of gamma-secretase inhibitors. Bioorg Med Chem Lett 15: 2685-8 (2005)
- Asberom, T; Bara, TA; Bennett, CE; Burnett, DA; Caplen, MA; Clader, JW; Cole, DJ; Domalski, MS; Josien, HB; Knutson, CE; Li, H; McBriar, MD; Pissarnitski, DA; Qiang, L; Rajagopalan, M; Sasikumar, TK; Su, J; Tang, H; Wu, W; Xu, R; Zhao, Z Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors US Patent US8569521 (2013)
- Bergstrom, CP; Sloan, CP; Lau, WY; Smith, DW; Zheng, M; Hansel, SB; Polson, CT; Corsa, JA; Barten, DM; Felsenstein, KM; Roberts, SB Carbamate-appended N-alkylsulfonamides as inhibitors of gamma-secretase. Bioorg Med Chem Lett 18: 464-8 (2008)
- Rodriguez, CE; Holmes, HM; Mlodnosky, KL; Lam, VQ; Berkman, CE Evaluation of phosphorus-containing inhibitors of gamma-glutamyl hydrolase. Bioorg Med Chem Lett 8: 1521-4 (1999)
- Bursavich, MG; Harrison, BA; Blain, JF Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon? J Med Chem 59: 7389-409 (2016)
- Debenham, SD; Chan, A; Lau, FW; Liu, W; Wood, HB; Lemme, K; Colwell, L; Habulihaz, B; Akiyama, TE; Einstein, M; Doebber, TW; Sharma, N; Wang, CF; Wu, M; Berger, JP; Meinke, PT Highly functionalized 7-azaindoles as selective PPAR gamma modulators. Bioorg Med Chem Lett 18: 4798-801 (2008)
- Bowers, S; Probst, GD; Truong, AP; Hom, RK; Konradi, AW; Sham, HL; Garofalo, AW; Wong, K; Goldbach, E; Quinn, KP; Sauer, JM; Wallace, W; Nguyen, L; Hemphill, SS; Bova, MP; Basi, GS N-Bridged bicyclic sulfonamides as inhibitors of gamma-secretase. Bioorg Med Chem Lett 19: 6952-6 (2009)
- Narlawar, R; Pérez Revuelta, BI; Baumann, K; Schubenel, R; Haass, C; Steiner, H; Schmidt, B N-Substituted carbazolyloxyacetic acids modulate Alzheimer associated gamma-secretase. Bioorg Med Chem Lett 17: 176-82 (2007)
- Baumann, S; Höttecke, N; Schubenel, R; Baumann, K; Schmidt, B NSAID-derived gamma-secretase modulators. Part III: Membrane anchoring. Bioorg Med Chem Lett 19: 6986-90 (2009)
- Bergstrom, CP; Sloan, CP; Wang, HH; Parker, MF; Smith, DW; Zheng, M; Hansel, SB; Polson, CT; Barber, LE; Bursuker, I; Guss, VL; Corsa, JA; Barten, DM; Felsenstein, KM; Roberts, SB Nitrogen-appended N-alkylsulfonamides as inhibitors of gamma-secretase. Bioorg Med Chem Lett 18: 175-8 (2008)
- Procopiou, PA; Biggadike, K; English, AF; Farrell, RM; Hagger, GN; Hancock, AP; Haase, MV; Irving, WR; Sareen, M; Snowden, MA; Solanke, YE; Tralau-Stewart, CJ; Walton, SE; Wood, JA Novel glucocorticoid antedrugs possessing a 17beta-(gamma-lactone) ring. J Med Chem 44: 602-12 (2001)
- Yang, G; Yin, YI; Chun, J; Shelton, CC; Ouerfelli, O; Li, YM Stereo-controlled synthesis of novel photoreactive gamma-secretase inhibitors. Bioorg Med Chem Lett 19: 922-5 (2009)
- Finsinger, D; Wucherer-Plietker, M; Blume, B Substituted tetrazolo[1,5-a]pyrazines as ROR-gamma inhibitors US Patent US9688684 (2017)
- Thompson, LA; Liauw, AY; Ramanjulu, MM; Kasireddy-Polam, P; Mercer, SE; Maduskuie, TP; Glicksman, M; Roach, AH; Meredith, JE; Liu, RQ; Combs, AP; Higaki, JN; Cordell, B; Seiffert, D; Zaczek, RC; Robertson, DW; Olson, RE Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitors. Bioorg Med Chem Lett 16: 2357-63 (2006)
- Matin, A; Gavande, N; Kim, MS; Yang, NX; Salam, NK; Hanrahan, JR; Roubin, RH; Hibbs, DE 7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists. J Med Chem 52: 6835-50 (2009)
- McCarthy, C; Went, N; Olsson, RI Indazole and indole derivatives as inhibitors of retinoic acid related orphan receptor gamma (ROR gamma) for the treatment of immune-related diseases US Patent US10383850 (2019)
- Rosowsky, A; Bader, H; Freisheim, JH Analogues of methotrexate and aminopterin with gamma-methylene and gamma-cyano substitution of the glutamate side chain: synthesis and in vitro biological activity. J Med Chem 34: 203-8 (1991)
- Cantin, LD; Liang, S; Ogutu, H; Iwuagwu, CI; Boakye, K; Bullock, WH; Burns, M; Clark, R; Claus, T; delaCruz, FE; Daly, M; Ehrgott, FJ; Johnson, JS; Keiper, C; Livingston, JN; Schoenleber, RW; Shapiro, J; Town, C; Yang, L; Tsutsumi, M; Ma, X Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups--new classes of PPAR gamma/delta and PPAR alpha/gamma/delta agonists. Bioorg Med Chem Lett 17: 1056-61 (2007)
- Michellys, PY; Ardecky, RJ; Chen, JH; Crombie, DL; Etgen, GJ; Faul, MM; Faulkner, AL; Grese, TA; Heyman, RA; Karanewsky, DS; Klausing, K; Leibowitz, MD; Liu, S; Mais, DA; Mapes, CM; Marschke, KB; Reifel-Miller, A; Ogilvie, KM; Rungta, D; Thompson, AW; Tyhonas, JS; Boehm, MF Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes. J Med Chem 46: 2683-96 (2003)
- Rynearson, KD; Buckle, RN; Herr, RJ; Mayhew, NJ; Chen, X; Paquette, WD; Sakwa, SA; Yang, J; Barnes, KD; Nguyen, P; Mobley, WC; Johnson, G; Lin, JH; Tanzi, RE; Wagner, SL Design and synthesis of novel methoxypyridine-derived gamma-secretase modulators. Bioorg Med Chem 28: (2020)
- Devasthale, PV; Chen, S; Jeon, Y; Qu, F; Ryono, DE; Wang, W; Zhang, H; Cheng, L; Farrelly, D; Golla, R; Grover, G; Ma, Z; Moore, L; Seethala, R; Sun, W; Doweyko, AM; Chandrasena, G; Sleph, P; Hariharan, N; Cheng, PT Discovery of tertiary aminoacids as dual PPARalpha/gamma agonists-I. Bioorg Med Chem Lett 17: 2312-6 (2007)
- Kottirsch, G; Tapparelli, C; Zerwes, HG Fibrinogen receptor antagonists containing a gamma-lactam Gly-Asp isostere Bioorg Med Chem Lett 3: 1675-1680 (1993)
- Yamagishi, K; Yamamoto, K; Mochizuki, Y; Nakano, T; Yamada, S; Tokiwa, H Flexible ligand recognition of peroxisome proliferator-activated receptor-gamma (PPARgamma). Bioorg Med Chem Lett 20: 3344-7 (2010)
- Decicco, CP; Nelson, DJ; Luo, Y; Shen, L; Horiuchi, KY; Amsler, KM; Foster, LA; Spitz, SM; Merrill, JJ; Sizemore, CF; Rogers, KC; Copeland, RA; Harpel, MR Glutamyl-gamma-boronate inhibitors of bacterial Glu-tRNA(Gln) amidotransferase. Bioorg Med Chem Lett 11: 2561-4 (2001)
- Santos, MA; Enyedy, EA; Nuti, E; Rossello, A; Krupenko, NI; Krupenko, SA Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs. Bioorg Med Chem 15: 1266-74 (2007)
- Ali, FE; Bondinell, WE; Dandridge, PA; Frazee, JS; Garvey, E; Girard, GR; Kaiser, C; Ku, TW; Lafferty, JJ; Moonsammy, GI Orally active and potent inhibitors of gamma-aminobutyric acid uptake. J Med Chem 28: 653-60 (1985)
- Dixit, A; Saxena, AK QSAR analysis of PPAR-gamma agonists as anti-diabetic agents. Eur J Med Chem 43: 73-80 (2008)
- Vaccaro, HA; Zhao, Z; Clader, JW; Song, L; Terracina, G; Zhang, L; Pissarnitski, DA Solution-phase parallel synthesis of carbamates as gamma-secretase inhibitors. J Comb Chem 10: 56-62 (2008)
- Bakshi, P; Wolfe, MS Stereochemical analysis of (hydroxyethyl)urea peptidomimetic inhibitors of gamma-secretase. J Med Chem 47: 6485-9 (2004)
- Bridoux, A; Millet, R; Pommery, J; Pommery, N; Henichart, JP Synthesis and biological activity of N-aroyl-tetrahydro-gamma-carbolines. Bioorg Med Chem 18: 3910-24 (2010)
- Lemke, TL; Cramer, MB; Adamski, SW; Pedone, CA; Brooker, G beta-Adrenergic blocking agents. alpha- and gamma-methyl(aryloxy)propanolamines. J Med Chem 24: 1211-4 (1981)
- ChEMBL_196640 (CHEMBL800753) Agonistic activity towards retinoid X receptor-gamma
- ChEMBL_196641 (CHEMBL800754) Antagonistic activity towards retinoid X receptor-gamma
- ChEMBL_196642 (CHEMBL800755) Selective activity towards retinoid X receptor-gamma
- ChEMBL_196643 (CHEMBL800756) Synergistic activity towards retinoid X receptor-gamma
- ChEMBL_197216 (CHEMBL798964) Transcriptional activation of Retinoid X receptor RXR gamma
- ChEMBL_197219 (CHEMBL798967) Transcriptional activation of Retinoid X receptor RXR gamma
- ChEMBL_197233 (CHEMBL801379) Transcriptional activation of Retinoid X receptor RXR gamma
- ChEMBL_196165 (CHEMBL804938) Inhibition of binding to retinoid A receptor RAR gamma
- ChEMBL_197227 (CHEMBL798203) Dissociation constant for binding to Retinoid X receptor gamma
- ChEMBL_2078854 (CHEMBL4734645) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells
- ChEMBL_197224 (CHEMBL798972) Inhibition of binding to murine Retinoid X receptor RXR gamma
- ChEMBL_197225 (CHEMBL798334) Inhibition of binding to murine Retinoid X receptor RXR gamma
- ChEMBL_197239 (CHEMBL803361) In vitro binding affinity for Retinoid X receptor RXR gamma
- ChEMBL_2260712 (CHEMBL5215723) Inhibition of IDO1 in IFN-gamma induced overexpressing human HeLa cells
- ChEMBL_1652013 (CHEMBL4001268) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells assessed as inhibition of kynurenine production preincubated with cells followed by IFN-gamma addition measured after 20 hrs
- ChEBML_196651 Transcriptional activation in CV-1 cells expressing retinoid X receptor RXR gamma
- ChEBML_197247 Transcriptional activation in CV-1 cells expressing Retinoid X receptor RXR gamma
- ChEMBL_197218 (CHEMBL798966) Inhibition of [3H]targretin binding to Retinoid X receptor RXR gamma
- ChEMBL_1363182 (CHEMBL3293897) Binding affinity to human recombinant IFN-gamma by surface plasmon resonance assay
- ChEBML_196910 Inhibition of [3H]-9-cis RA binding to Retinoid X receptor RXR gamma
- ChEBML_197221 Transcriptional activation in CV-1 cells expressing mouse Retinoid X receptor RXR gamma
- ChEBML_197238 Inhibition of [3H]-9-cis RA binding to Retinoid X receptor RXR gamma
- ChEMBL_164862 (CHEMBL772121) Transcriptional activation in CV-1 cells expressing retinoid X receptor RXR gamma
- ChEMBL_196161 (CHEMBL804934) Transcriptional activation in CV-1 cells expressing retinoid A receptor RAR gamma
- ChEMBL_196162 (CHEMBL804935) Transcriptional activation in CV-1 cells expressing retinoid A receptor RAR gamma
- ChEMBL_196601 (CHEMBL799679) Transcriptional activation in CV-1 cells expressing retinoid X receptor RXR gamma
- ChEMBL_196647 (CHEMBL800760) Transcriptional activation in CV-1 cells expressing retinoid X receptor RXR gamma
- ChEMBL_196650 (CHEMBL800763) Transcriptional activation in CV-1 cells expressing retinoid X receptor RXR gamma
- ChEMBL_196651 (CHEMBL800764) Transcriptional activation in CV-1 cells expressing retinoid X receptor RXR gamma
- ChEMBL_197231 (CHEMBL801377) Transcriptional activation in CV-1 cells expressing Retinoid X receptor RXR gamma
- ChEMBL_1753388 (CHEMBL4188148) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells assessed as inhibition of kynurenine production pre-incubated for 1 hr followed by IFN-gamma addition and measured after 18 hrs
- ChEMBL_1737497 (CHEMBL4153247) Antagonist activity at P2X7 in LPS/IFN gamma differentiated human THP-1 cells
- ChEBML_197228 Inhibition of [3H]-9-cis-RA binding to human Retinoid X receptor RXR gamma
- ChEMBL_196646 (CHEMBL800759) Effective concentration against retinoid receptor isoform (RXR gamma) expressed in CV-1 cells
- ChEMBL_196663 (CHEMBL799698) Effective concentration against retinoid receptor isoform (RAR gamma) expressed in CV-1 cells
- ChEMBL_197217 (CHEMBL798965) Transcriptional activation of CV-1 cells expressing murine Retinoid X receptor RXR gamma
- ChEMBL_197229 (CHEMBL798205) Inhibition of [3H]9-cis-RA binding to Retinoid X receptor RXR gamma
- ChEMBL_197241 (CHEMBL803363) Inhibition of [3H]9-cis-RA binding to Retinoid X receptor RXR gamma
- ChEMBL_2078875 (CHEMBL4734666) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells centrifuged for 10 mins
- ChEMBL_1650863 (CHEMBL3999997) Inhibition of IDO1 in IFN-gamma/LPS-stimulated human whole blood assessed as decrease in kynurenine levels preincubated for 15 mins followed by IFN-gamma/LPS stimulation for overnight by LC/MS/MS analysis
- ChEMBL_196648 (CHEMBL800761) Inhibition of [3H]9-cis-RA binding to baculovirus expressed retinoid receptor RXR gamma
- ChEMBL_1838987 (CHEMBL4339120) Inhibition IDO1 in LPS/IFN-gamma stimulated human whole blood assessed as reduction in tryptophan/kynurenine level preincubated for 15 mins followed by LPS/IFN-gamma stimulation measured after 20 hrs by LC-MS/MS analysis
- ChEBML_196011 Inhibition of 3[H]ATRA binding to retinoid acid receptor gamma expressed in CV-1 cells
- ChEBML_197222 Effective potency in transcriptional activation assay in CV-1 cells expressing Retinoid X receptor RXR gamma
- ChEMBL_1670928 (CHEMBL4020957) Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay
- ChEMBL_2526317 Inhibition of JAK1/JAK2 in human whole blood assessed as reduction in IFN-gamma-induced STAT1 phosphorylation in monocytes preincubated for 1 hr followed by IFN-gamma stimulation and measured after 8 to 20 mins by FACS analysis
- ChEMBL_853436 (CHEMBL2155294) Inhibition of COX2-mediated 2-arachidonoylglycerol oxygenation in LPS/IFN-gamma-stimulated mouse RAW264.7 cells assessed as 2-AG to PGE2-G/PGD2-G conversion treated 2 hrs after LPS/IFN-gamma stimulation measured after 6 hrs
- ChEMBL_2545854 Inhibition of JAK1/JAK2 signaling pathway in human U2OS cells assessed as reduction in IFN-gamma-induced STAT1 phosphorylation preincubated with compound for 1 hr followed by IFN-gamma addition and measured after 1 hr by TR-FRET analysis
- ChEMBL_197222 (CHEMBL798970) Effective potency in transcriptional activation assay in CV-1 cells expressing Retinoid X receptor RXR gamma
- ChEMBL_35147 (CHEMBL648510) Effective potency in transcriptional activation assay in CV-1 cells expressing Retinoid X receptor RXR gamma
- ChEMBL_2107563 (CHEMBL4816238) Inhibition of IFN-gamma-induced STAT1 transcriptional activity in human HepG2 cells by luciferase reporter gene assay
- ChEMBL_2119554 (CHEMBL4828620) Inhibition of IDO1 in IFN-gamma induced human HeLa cells measured after 48 hrs by fluorescence assay
- ChEMBL_2316503 Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysis
- ChEMBL_1909137 (CHEMBL4411583) Inhibition of JAK1/JAK2 signaling pathway in human CD14 +ve cells of whole blood assessed as reduction in IFN-gamma induced STAT1 phosphorylation preincubated for 45 mins followed by IFN-gamma addition and measured measured after 15 mins by FACS assay
- ChEMBL_196664 (CHEMBL803397) Tested for binding affinity against [3H]-ATRA binding to retinoid receptor isoform (RAR gamma) expressed in baculovirus
- ChEMBL_1685554 (CHEMBL4036033) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells using L-tryptophan as substrate after 24 hrs
- ChEMBL_1779693 (CHEMBL4236685) Inhibition of IFN-gamma-stimulated IDO1 in human HeLa cells after 24 hrs by Ehrlich's reagent based assay
- ChEMBL_590887 (CHEMBL1042997) Inhibition of indoleamine 2,3-dioxygenase in IFN-gamma-stimulated human HeLa cells assessed as kynurenine formation by spectrophotometry
- ChEMBL_652247 (CHEMBL1225450) Inhibition of indoleamine-2,3-dioxygenase in human A431 cells assessed as inhibition of IFN-gamma-stimulated kynurenine production
- ChEMBL_1650851 (CHEMBL3999985) Inhibition of IDO1 in IFN-gamma-stimulated human HeLa cells assessed as decrease in kynurenine levels after 48 hrs
- ChEMBL_1784807 (CHEMBL4256324) Inhibition of IDO1 in IFN-gamma-stimulated human HeLa cells assessed as decrease in kynurenine levels after 48 hrs
- ChEMBL_1913238 (CHEMBL4415821) Inhibition of IDO1 in IFN-gamma-stimulated human HeLa cells assessed as decrease in kynurenine levels after 48 hrs
- ChEMBL_2124799 (CHEMBL4834032) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells incubated for 48 hrs by fluorescence microplate reader assay
- ChEMBL_2022039 (CHEMBL4675852) Inhibition of JAK1/JAK2 signaling pathway in human whole blood spiked with CD14 +ve cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation preincubated for 45 mins followed by IFN-gamma addition and measured measured after 15 mins immunostaining based by FACS assay
- ChEMBL_2035528 (CHEMBL4689686) Inhibition of IDO1 in LPS and IFN-gamma-stimulated human Whole blood assessed as reduction in kynurenine production using isotope-labeled tryptophan as substrate incubated for 15 mins followed by LPS and IFN-gamma stimulation measured after 18 hrs by LC-MS/MS analysis
- ChEMBL_1855397 (CHEMBL4356126) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells assessed as reduction in kynurenine production incubated for 18 hrs
- ChEMBL_1869802 (CHEMBL4370868) Inhibition of IDO1 in IFN-gamma-induced human HeLa cells assessed as reduction in L-kynurenine level after 24 hrs
- ChEMBL_2069926 (CHEMBL4725179) Inhibition of IDO1 in recombinant IFN-gamma induced human HeLa cells incubated for 18 hrs by fluorescence microplate reader assay
- ChEMBL_2069927 (CHEMBL4725180) Inhibition of IDO1 in recombinant IFN-gamma induced mouse M109 cells incubated for 18 hrs by fluorescence microplate reader assay
- ChEMBL_2078890 (CHEMBL4734681) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells incubated for 6 hrs by p-dimethylaminobenzaldehyde reagent based assay
- ChEMBL_2207937 (CHEMBL5120645) Inhibition of JAK1/JAK2 signaling pathway in human U-937 cells assessed as reduction of IFN-gamma induced ICAM1 expression
- ChEMBL_2246301 (CHEMBL5160511) Inhibition of IDO1 in IFN gamma-stimulated human HeLa cells measured after 48 hrs by fluorescence based microplate reader assay
- ChEMBL_1758066 (CHEMBL4193074) Inhibition of IFN-gamma stimulated STAT3 (unknown origin) expressed in human HeLa cells after 6 hrs by luciferase reporter gene assay
- ChEMBL_1936260 (CHEMBL4482019) Inhibition of IDO1 in IFN-gamma/LPS stimulated human THP-1 cells assessed as reduction in kynurenine production after 24 hrs
- ChEMBL_2078894 (CHEMBL4734685) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells incubated for 48 hrs by p-dimethylaminobenzaldehyde reagent based colorimetric assay
- ChEMBL_164867 (CHEMBL772126) Synergistic activation of BRL-49653 mediated PPAR gamma and retinoid X receptor alpha expressed in CV-1 cell transcriptional activation assay
- ChEBML_1703591 Inhibition of JAK1/JAK3 in human whole blood assessed as reduction in IL-2 induced IFN-gamma production after 18 hrs by ELISA
- ChEMBL_1546967 (CHEMBL3748070) Inhibition of IFN-gamma-stimulated IDO1 activity in human HeLa cells using L-tryptophan as substrate after 48 hrs by spectrophotometric analysis
- ChEMBL_1576410 (CHEMBL3802839) Inhibition of IFN gamma-induced STAT3 (unknown origin) activation in HeLa-STAT3-Luc cells after 6 hrs by luciferase reporter gene assay
- ChEMBL_1988859 (CHEMBL4622406) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells using L-tryptophan as substrate incubated for 48 hrs by fluorescence assay
- ChEMBL_2078858 (CHEMBL4734649) Inhibition of IDO1 in IFN-gamma-stimulated human HeLa cells incubated for 48 hrs using L-tryptophan as substrate by absorbance method
- ChEBML_196652 Compound was tested for functional activity in CV-1 cells transfected with an expression vector for retinoid X receptor gamma using transactivation assay
- ChEMBL_1546974 (CHEMBL3748077) Inhibition of IFN-gamma-stimulated IDO1 activity in human HeLa cells using L-tryptophan as substrate after 48 hrs by microplate reader analysis
- ChEMBL_1703591 (CHEMBL4054824) Inhibition of JAK1/JAK3 in human whole blood assessed as reduction in IL-2 induced IFN-gamma production after 18 hrs by ELISA
- ChEMBL_1857722 (CHEMBL4358451) Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assay
- ChEMBL_1857750 (CHEMBL4358479) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assay
- ChEMBL_1936259 (CHEMBL4482018) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells assessed as reduction in kynurenine production incubated for 24 hrs relative to control
- ChEMBL_2224438 (CHEMBL5137951) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells in presence of heme measured after 20 hrs by heme-competitive binding assay
- ChEMBL_2491108 Inhibition of IDO1 in IFN-gamma induced human HeLa cells using L-tryptophan as substrate incubated for 24 hrs by absorbance based microplate analysis
- ChEMBL_196652 (CHEMBL800765) Compound was tested for functional activity in CV-1 cells transfected with an expression vector for retinoid X receptor gamma using transactivation assay
- ChEMBL_196483 (CHEMBL798297) Agonistic activity towards retinoid X receptor-alpha
- ChEMBL_196484 (CHEMBL798298) Agonistic activity towards retinoid X receptor-alpha
- ChEMBL_196485 (CHEMBL798299) Antagonistic activity towards retinoid X receptor-alpha
- ChEMBL_196487 (CHEMBL798301) Selective activity towards retinoid X receptor-alpha
- ChEMBL_196488 (CHEMBL798302) Synergistic activity towards retinoid X receptor-alpha
- ChEMBL_196504 (CHEMBL798318) Agonistic activity towards retinoid X receptor-beta
- ChEMBL_196505 (CHEMBL798319) Antagonistic activity towards retinoid X receptor-beta
- ChEMBL_196506 (CHEMBL798320) Selective activity towards retinoid X receptor-beta
- ChEMBL_196507 (CHEMBL798321) Synergistic activity towards retinoid X receptor-beta
- ChEMBL_320731 (CHEMBL880876) Dissociation constant for Retinoid X receptor alpha
- ChEMBL_2015001 (CHEMBL4668579) Inhibition of LPS/IFN-gamma induced NO-dependent iNOS activity in mouse RAW 264.7 cells incubated for 16 hrs by Griess reagent based assay
- ChEMBL_2069931 (CHEMBL4725184) Inhibition of IDO1 in IFN-gamma/LPS induced human whole blood assessed as tryptophan/kynurenine level measured after 18 hrs by RapidFire mass spectrometry
- ChEMBL_2078869 (CHEMBL4734660) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells using L-Trp as substrate incubated for 48 hrs by Ehrlich reagent based assay
- ChEMBL_2078872 (CHEMBL4734663) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells assessed as effect on KYN level incubated for 48 hrs by rapidfire-mass spectrometry
- ChEMBL_1707523 (CHEMBL4058756) Inhibition of IDO-1 in IFN-gamma-stimulated human HeLa cells assessed as decrease in kynurenine production after 16 to 24 hrs by PDMAB method
- ChEMBL_1759370 (CHEMBL4194378) Inhibition of IDO1 in human IFN-gamma stimulated human HeLa cells assessed as inhibition of kynurenine production using L-tryptophan substrate incubated for 24 hrs
- ChEMBL_1907196 (CHEMBL4409554) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells assessed as reduction in kynurenine production using L-tryptophan as substrate incubated for 24 hrs
- ChEMBL_2078877 (CHEMBL4734668) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells assessed as effect on kynurenine level incubated for 48 hrs by p-dimethylaminobenzaldehyde based assay
- ChEMBL_1832159 (CHEMBL4332167) Antagonist activity at retinoid X receptor (unknown origin)
- ChEMBL_196751 (CHEMBL803332) Transcriptional activation of Retinoid X receptor RXR alpha
- ChEMBL_196752 (CHEMBL879251) Transcriptional ativation of Retinoid X receptor RXR alpha
- ChEMBL_196780 (CHEMBL799565) Transcriptional activation of Retinoid X receptor RXR alpha
- ChEMBL_196782 (CHEMBL799567) Transcriptional activation of Retinoid X receptor RXR alpha
- ChEMBL_196900 (CHEMBL807184) Transcriptional activation of retinoid X receptor RXR alpha
- ChEMBL_196905 (CHEMBL807367) Transcriptional activation of Retinoid X receptor RXR alpha
- ChEMBL_197056 (CHEMBL804832) Transcriptional activation of Retinoid X receptor RXR beta
- ChEMBL_197059 (CHEMBL804835) Transcriptional activation of Retinoid X receptor RXR beta
- ChEMBL_197060 (CHEMBL804836) Transcriptional activation of Retinoid X receptor RXR beta
- ChEMBL_197073 (CHEMBL806661) Effective concentrations against Retinoid X receptor RXR beta
- ChEMBL_1707524 (CHEMBL4058757) Inhibition of IDO-1 in IFN-gamma/LPS-stimulated human THP1 cells assessed as decrease in kynurenine production after 16 to 24 hrs by PDMAB method
- ChEMBL_1707525 (CHEMBL4058758) Inhibition of IDO-1 in IFN-gamma/LPS-stimulated human whole blood assessed as decrease in kynurenine production after 24 hrs by LC-MS/MS method
- ChEMBL_2054791 (CHEMBL4709792) Inhibition of IDO1 in IFN-gamma-induced human HeLa cells assessed as reduction in L-kynurenine formation using L-tryptophan as substrate incubated for 24 hrs
- ChEMBL_1923386 (CHEMBL4426342) Inhibition of CDK8 in IFN-gamma-induced human HCT116 cells assessed as suppression of STAT1 phosphorylation at serine727 residue incubated for 24 hrs by infrared scanning analysis
- ChEMBL_2078855 (CHEMBL4734646) Inhibition of IDO1 in human HeLa cells preincubated for 1 hr followed by IFN-gamma stimulation and measured after 20 hrs by Ehrlich colorimetric reagent based assay
- ChEBML_196902 Transcriptional activation of retinoid X receptor RXR alpha; not active
- ChEMBL_195186 (CHEMBL802719) Inhibition of binding to retinoid A receptor RAR alpha
- ChEMBL_195641 (CHEMBL795959) Inhibition of binding to retinoid A receptor RAR beta
- ChEMBL_196495 (CHEMBL798309) Inhibition of binding to retinoid X receptor RXR alpha
- ChEMBL_196765 (CHEMBL797917) Binding affinity for human Retinoid X receptor RXR alpha
- ChEMBL_196785 (CHEMBL799729) Dissociation constant for binding to Retinoid X receptor alpha
- ChEMBL_197068 (CHEMBL806657) Dissociation constant for binding to Retinoid X receptor beta
- ChEMBL_2184624 (CHEMBL5096706) Agonist activity at mouse STING assessed as IFN-beta secretion
- ChEMBL_1994392 (CHEMBL4628287) Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells assessed as reduction in kynurenine formation using L-tryptophan as substrate incubated for 24 hrs by UV-spectrophotometry
- ChEMBL_196767 (CHEMBL798078) Inhibition of binding to human Retinoid X receptor RXR alpha
- ChEMBL_196784 (CHEMBL799728) Inhibition of binding to murine Retinoid X receptor RXR alpha
- ChEMBL_196911 (CHEMBL807373) In vitro binding affinity for Retinoid X receptor RXR alpha
- ChEMBL_197066 (CHEMBL806655) Inhibition of binding to murine Retinoid X receptor RXR beta
- Ligand Binding Assay Binding assay using human retinoid X receptor alpha (RXR).
- ChEMBL_1855446 (CHEMBL4356175) Inhibition of IFN-gamma stimulated IDO1 in human HeLa cells assessed as reduction in formation of kynurenine incubated for 48 hrs in presence of IFNgamma by microplate reader assay
- ChEMBL_2035521 (CHEMBL4689679) Inhibition of IDO1 in IFN-gamma-stimulated human HeLa cells assessed as reduction in kynurenine production using L-Tryptophan as substrate incubated for 48 hrs by fluorescence based assay
- ChEMBL_2046340 (CHEMBL4701039) Antagonist activity at adenosine 2A receptor in BALB/c mouse T cells assessed as reduction in CGS-21680-induced suppression of IFN-gamma secretion incubated for 24 hrs by ELISA
- ChEMBL_2162573 (CHEMBL5047434) Inhibition of JAK1/JAK3 signalling in human PBMC assessed as inhibition of IL-2 stimulated IFN-gamma release incubated for 1 hr followed by IL-2 stimulation by MSD assay
- ChEMBL_2285162 Inhibition of IFN-alpha induced STAT3 phosphorylation in human PBMC preincubated with compound for 30 mins followed by IFN-alpha stimulation and measured after 15 mins by flow cytometric analysis
- ChEBML_196497 Transcriptional activation in CV-1 cells expressing retinoid X receptor RXR alpha
- ChEBML_197086 Transcriptional activation in CV-1 cells expressing Retinoid X receptor RXR beta
- ChEMBL_196594 (CHEMBL800472) Transcriptional activation in CV-1 cells expressing Retinoid X receptor alpha
- ChEMBL_196769 (CHEMBL798930) Inhibition of [3H]targretin binding to Retinoid X receptor RXR alpha
- ChEMBL_196781 (CHEMBL799566) Transcriptional activation of Retinoid X receptor RXR alpha;NA=not active
- ChEMBL_197058 (CHEMBL804834) Inhibition of [3H]-Targretin binding to Retinoid X receptor RXR beta
- ChEMBL_1843570 (CHEMBL4343997) Inhibition of STING in human THP1 cells by IFN reporter gene assay
- ChEMBL_1349852 (CHEMBL3268428) Inhibition of Stat1 (unknown origin)-induced human CXCL10 (972 bp) promoter activity expressed in TNF-alpha/IFN-gamma/IL-1beta-stimulated human DLD1 cells after 24 hrs by luciferase reporter assay
- ChEMBL_1513935 (CHEMBL3611617) Antagonist activity at Kv1.3 in human whole blood assessed as inhibition of thapsigargin-induced IFN-gamma secretion incubated for 30 prior to thapsigargin induction measured after 48 hrs by electrochemilluminescent immunoassay
- ChEMBL_1620337 (CHEMBL3862620) Inhibition of IFNgamma-induced STAT3 activation in human HeLa cells expressing STAT3 (unknown origin) preincubated for 15 mins followed by IFN-gamma addition measured after 6 hrs by luciferase reporter gene assay
- ChEBML_196753 Transcriptional activation in CV-1 cells expressing human Retinoid X receptor RXR-alpha
- ChEBML_197079 Inhibition of [3H]-9-cis RA binding to Retinoid X receptor RXR beta
- ChEMBL_164850 (CHEMBL769008) Transcriptional activation in CV-1 cells expressing retinoid X receptor RXR alpha
- ChEMBL_164860 (CHEMBL772119) Transcriptional activation in CV-1 cells expressing retinoid X receptor RXR beta
- ChEMBL_195182 (CHEMBL801815) Transcriptional activation in CV-1 cells expressing retinoid A receptor RAR alpha
- ChEMBL_195183 (CHEMBL801816) Transcriptional activation in CV-1 cells expressing retinoid A receptor RAR alpha
- ChEMBL_195638 (CHEMBL795956) Transcriptional activation in CV-1 cells expressing retinoid A receptor RAR beta
- ChEMBL_195639 (CHEMBL795957) Transcriptional activation in CV-1 cells expressing retinoid A receptor RAR beta
- ChEMBL_196471 (CHEMBL799618) Inhibition of [3H]ATRA binding to baculovirus expressed retinoid receptor RAR alpha
- ChEMBL_196473 (CHEMBL799784) Effective concentration for Retinoid X receptor alpha activity in CV-1 cells
- ChEMBL_196492 (CHEMBL798306) Transcriptional activation in CV-1 cells expressing retinoid X receptor RXR alpha
- ChEMBL_196493 (CHEMBL798307) Transcriptional activation in CV-1 cells expressing retinoid X receptor RXR alpha
- ChEMBL_196494 (CHEMBL798308) Transcriptional activation in CV-1 cells expressing retinoid X receptor RXR alpha
- ChEMBL_196497 (CHEMBL798311) Transcriptional activation in CV-1 cells expressing retinoid X receptor RXR alpha
- ChEMBL_196633 (CHEMBL879143) Transcriptional activation in CV-1 cells expressing retinoid X receptor RXR beta
- ChEMBL_196659 (CHEMBL799694) Inhibition of [3H]ATRA binding to baculovirus expressed retinoid receptor RAR beta
- ChEMBL_196903 (CHEMBL807187) Transcriptional activation in CV-1 cells expressing Retinoid X receptor RXR alpha
- ChEMBL_197074 (CHEMBL806662) Transcriptional activation in CV-1 cells expressing Retinoid X receptor RXR beta
- ChEMBL_197407 (CHEMBL799797) Inhibition of [3H]-ATRA binding to baculovirus expressed retinoid receptor RAR alpha
- ChEMBL_2373096 Agonist activity at STING in human THP-1 cells by IFN-reporter based assay
- ChEMBL_2292020 Inhibition of JAK1/TYK2 in human M07E cells assessed as reduction of IFN alpha stimulated STAT phosphorylation preincubated for 30 mins followed by IFN alpha stimulation for 15 mins by flow cytometry method
- ChEMBL_1555055 (CHEMBL3767633) Inhibition of IFN gamma induced human IDO1 in HeLa cells assessed as reduction in kynurenine production treated with 3-fold serial dilution beginning at 100 uM after 24 hrs by microtiter plate reader
- ChEMBL_1555056 (CHEMBL3767634) Inhibition of IFN gamma induced human IDO1 in HeLa cells assessed as reduction in kynurenine production treated with 5-fold serial dilution beginning at 400 uM after 24 hrs by microtiter plate reader
- ChEBML_197069 Inhibition of [3H]9-cis-RA binding to mouse Retinoid X receptor RXR beta
- ChEMBL_196472 (CHEMBL879373) Effective concentration against retinoid receptor isoform (RXR alpha) expressed in CV-1 cells
- ChEMBL_196630 (CHEMBL798184) Effective concentration against retinoid receptor isoform (RXR beta) expressed in CV-1 cells
- ChEMBL_196658 (CHEMBL799693) Effective concentration against retinoid receptor isoform (RAR beta) expressed in CV-1 cells
- ChEMBL_196753 (CHEMBL803333) Transcriptional activation in CV-1 cells expressing human Retinoid X receptor RXR-alpha
- ChEMBL_196757 (CHEMBL800546) Transcriptional activation of CV-1 cells expressing murine Retinoid X receptor RXR alpha
- ChEMBL_196772 (CHEMBL798933) Inhibition of [3H]9-cis-RA binding to Retinoid X receptor RXR alpha
- ChEMBL_196912 (CHEMBL807374) Relative activity against Retinoid X receptor RXR-alpha compared to 9-cis-RA
- ChEMBL_196914 (CHEMBL807376) Inhibition of [3H]9-cis-RA binding to Retinoid X receptor RXR alpha
- ChEMBL_197057 (CHEMBL804833) Transcriptional activation of CV-1 cells expressing murine Retinoid X receptor RXR beta
- ChEMBL_197062 (CHEMBL807509) Transcriptional activation in CV-1 cells expressing mouse Retinoid X receptor RXR beta
- ChEMBL_197070 (CHEMBL806659) Inhibition of [3H]9-cis-RA binding to Retinoid X receptor RXR beta
- ChEMBL_197071 (CHEMBL806660) Inhibition of [3H]-9-cis-RA binding to Retinoid X receptor RXR beta
- ChEMBL_197081 (CHEMBL806010) Inhibition of [3H]9-cis-RA binding to Retinoid X receptor RXR beta
- ChEMBL_197386 (CHEMBL799705) Effective concentration against retinoid receptor isoform (RAR alpha) expressed in CV-1 cells
- ChEMBL_161149 (CHEMBL767417) Inhibition of Protein kinase C gamma (PKC-gamma)
- ChEMBL_1350279 (CHEMBL3267262) Binding affinity to IFNAR (unknown origin) assessed as inhibition of interaction with IFN-alpha
- ChEMBL_1368159 (CHEMBL3299207) Inhibition of JAK1/TYK2 in human whole blood assessed as inhibition of IFN-alpha-induced STAT-3 phosphorylation preincubated for 45 mins followed by IFN-alpha addition measured after 15 mins by FACS analysis
- ChEMBL_2309268 Inhibition of JAK1/TYK2 in human M07E cells assessed as reduction of IFN alpha stimulated STAT phosphorylation preincubated for 30 mins followed by IFN alpha stimulation and measured after 15 mins by flow cytometry method
- ChEBML_154356 Binding affinity towards peroxisome proliferator activated receptor gamma (PPAR gamma)
- ChEBML_154541 Binding affinity for Peroxisome proliferator activated receptor gamma (PPAR gamma)
- ChEMBL_196000 (CHEMBL800489) Binding affinity for Retinoic Acid Receptor gamma (RAR gamma)
- ChEMBL_1722940 (CHEMBL4137940) Inverse agonist activity at RORgammat in human PBMC-derived CD4-positive Th-17 polarized cells assessed as reduction in IL4/anti-IFN-gamma antibody-stimulated IL-17 secretion after 48 to 72 hrs by ELISA
- ChEMBL_1737460 (CHEMBL4153210) Antagonist activity at P2X7 in LPS/IFN gamma differentiated human THP-1 cells assessed as inhibition of BzATP-induced IL-1beta release preincubated for 30 mins followed by BzATP stimulation for 30 mins by ELISA
- ChEMBL_196475 (CHEMBL799786) Effective concentration for Retinoid X receptor alpha activity in CV-1 cells; Partial agonist
- ChEMBL_196482 (CHEMBL798296) Inhibition of [3H]9-cis-RA binding to baculovirus expressed retinoid receptor RXR alpha
- ChEMBL_196486 (CHEMBL798300) Binding affinity for retinoid X receptor alpha (RXRalpha), using 9-cis-[3H]-retinoic acid
- ChEMBL_196631 (CHEMBL798185) Inhibition of [3H]9-cis-RA binding to baculovirus expressed retinoid receptor RXR beta
- ChEMBL_196754 (CHEMBL800543) Transcriptional activation assay in CV-1 cells expressing human retinoid X receptor RXR alpha
- ChEMBL_196766 (CHEMBL798077) Inhibition of [3H]9-cis-RA binding to human Retinoid X receptor RXR alpha
- ChEMBL_197069 (CHEMBL806658) Inhibition of [3H]9-cis-RA binding to mouse Retinoid X receptor RXR beta
- ChEMBL_2116726 (CHEMBL4825792) Inhibition of TYK2/JAK1 signaling pathway in human whole blood assessed as reduction in IFN-alpha induced STAT3 phosphorylation incubated for 60 mins followed by IFN-alpha addition and measured after 20 mins by fluorescence assay
- ChEMBL_1473820 (CHEMBL3418719) Antagonist activity at P2X7 receptor in LPS/IFN-gamma-differentiated human THP1 cells assessed as inhibition of BzATP-induced IL-1beta release preincubated for 30 mins followed by BzATP induction measured after 30 mins by ELISA
- ChEMBL_154356 (CHEMBL759117) Binding affinity towards peroxisome proliferator activated receptor gamma (PPAR gamma)
- ChEMBL_154522 (CHEMBL762149) Binding affinity against Peroxisome proliferator activated receptor gamma (PPAR gamma)
- ChEMBL_154525 (CHEMBL762152) Binding affinity against peroxisome proliferator activated receptor gamma (PPAR-gamma)
- ChEMBL_2526316 Inhibition of JAK1/TYK2 in human whole blood assessed as reduction in IFN-alpha-induced STAT1 phosphorylation in monocytes preincubated for 1 hr followed by IFN-alpha stimulation and measured after 8 to 20 mins by FACS analysis
- ChEBML_41856 Effective potency in transcriptional activation assay in CV-1 cells expressing Retinoid X receptor RXR beta
- ChEMBL_1843571 (CHEMBL4343998) Inhibition of STING in human THP1 cells in presence of PFO by IFN reporter gene assay
- ChEMBL_1843574 (CHEMBL4344001) Inhibition of STING in human THP1 cells in presence of digitonin by IFN reporter gene assay
- ChEMBL_1931156 (CHEMBL4434407) Inhibition of TYK2 in human whole blood assessed as reduction in IFN-alpha stimulated TYK2 phosphorylation
- ChEMBL_2094265 (CHEMBL4775528) Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay
- ChEMBL_2353683 Inhibition of TYK2 signalling pathway in human PBMC cells assessed as IFN alpha induced p-STAT1 level
- ChEMBL_2353684 Inhibition of TYK2 signalling pathway in human PBMC cells assessed as IFN alpha induced p-STAT3 level
- ChEMBL_1909136 (CHEMBL4411582) Inhibition of JAK1/TYK2 signaling pathway in human lymphocytes of whole blood assessed as reduction in IFN-alpha induced STAT3 phosphorylation preincubated for 45 mins followed by IFN-alpha addition and measured measured after 15 mins by FACS assay
- ChEMBL_2022031 (CHEMBL4675844) Inhibition of JAK1/TYK2 signaling pathway in human whole blood lymphocytes assessed as reduction in IFN-alpha induced STAT3 phosphorylation preincubated for 45 mins followed by IFN-alpha addition and measured measured after 15 mins by FACS assay
- ChEMBL_2240650 (CHEMBL5154546) Inhibition of JAK1/TYK2 signalling in human whole blood assessed as inhibition of IFN-alpha stimulated STAT1 phosphorylation in CD4+ lymphocytes preincubated for 1 hr followed by IFN-alpha stimulation and incubated for 20 mins by flow cytometry analysis
- ChEMBL_2526313 Inhibition of JAK1/TYK2 in human whole blood assessed as reduction in IFN-alpha-induced STAT1 phosphorylation in CD3+ T cells preincubated for 1 hr followed by IFN-alpha stimulation and measured after 8 to 20 mins by FACS analysis
- ChEMBL_2545852 Inhibition of JAK1/TYK2 signaling pathway in human U2OS cells assessed as reduction in IFN-alphaB2-induced STAT1 phosphorylation preincubated with compound for 1 hr followed by IFN-alphaB2 addition and measured after 1 hr by TR-FRET analysis
- ChEBML_154188 In vitro activation of human peroxisome proliferator activated receptor gamma (PPAR gamma)
- ChEMBL_154215 (CHEMBL759460) Binding affinity against human Peroxisome proliferator activated receptor gamma (PPAR gamma)
- ChEMBL_305792 (CHEMBL827980) Inhibition of human Protein kinase C gamma using [gamma-33P]-ATP
- ChEMBL_1933658 (CHEMBL4479310) Antagonist activity at human P2X7 receptor in LPS/IFN-gamma-differentiated human THP-1 cells assessed as suppression of BzATP-stimulated IL-1beta release per-incubated for 30 mins before BzATP addition and measured after 30 mins by ELISA
- ChEMBL_2062459 (CHEMBL4717712) Inhibition of human IDO1 in IFN-gamma-induced human MDA-MB-231 cells assessed as N-formylkynurenine formation using L-tryptophan as substrate pretreated for 4 hrs followed substrate addition measured after 5 hrs by UV-vis spectrophotometric analysis
- ChEMBL_2376406 Inhibition of IDO1 in IFN-gamma-induced human HeLa cells assessed as reduction in N-formylkynurenine formation using L-tryptophan as substrate preincubated for 24 hrs followed by substrate addition and measured after 30 mins by SpectraMax microplate reader analysis
- ChEMBL_196624 (CHEMBL800659) Ability to displace [3H]9-cis-RA from Retinoid X receptor alpha in CV-1 cells
- ChEMBL_196755 (CHEMBL800544) Effective potency in transcriptional activation assay in CV-1 cells expressing Retinoid X receptor RXR alpha
- ChEMBL_197063 (CHEMBL806652) Effective potency in transcriptional activation assay in CV-1 cells expressing Retinoid X receptor RXR beta
- ChEMBL_41856 (CHEMBL650724) Effective potency in transcriptional activation assay in CV-1 cells expressing Retinoid X receptor RXR beta
- ChEBML_153616 In vitro transcription activation on human peroxisome proliferator activated receptor-gamma (PPAR gamma)
- ChEBML_222303 In vitro binding affinity against human PPAR gamma (peroxisome proliferator-activated gamma receptor)
- ChEMBL_2545868 Inhibition of JAK1/TYK2 in human whole blood assessed as reduction in IFN-alpha-induced STAT1 phosphorylation in CD4+ T cells preincubated with compound for 30 mins followed by IFN-alpha addition and measured after 20 mins by flow cytometry analysis
- ChEMBL_154361 (CHEMBL756623) In vitro binding affinity towards human peroxisome proliferator activated receptor gamma (PPAR gamma)
- ChEMBL_154548 (CHEMBL757883) In vitro binding affinity against human PPAR gamma (peroxisome proliferator-activated gamma receptor)
- ChEMBL_222303 (CHEMBL841917) In vitro binding affinity against human PPAR gamma (peroxisome proliferator-activated gamma receptor)
- ChEMBL_196476 (CHEMBL799787) Effective concentration for lipogenesis induced by retinoid X receptor alpha in C3H10T1/2 clone 8 fibroblast cells
- ChEMBL_2184645 (CHEMBL5096727) Antagonist activity at STING (unknown origin) in L929 cells assessed as IFN-beta RNA level q-RTPCR analysis
- ChEBML_154534 Agonist activity against PPAR gamma
- ChEBML_68901 Inhibitory activity against gamma-secretase
- ChEMBL_358169 (CHEMBL854203) Inhibition of gamma secretase
- ChEMBL_364830 (CHEMBL870177) Inhibition of PPAR gamma
- ChEMBL_389284 (CHEMBL868040) Inhibition of PTP gamma
- ChEMBL_438619 (CHEMBL888950) Inhibition of gamma-secretase
- ChEMBL_453103 (CHEMBL902249) Inhibition of Gamma-secretase
- ChEMBL_458481 (CHEMBL941797) Inhibition of PKC gamma
- ChEMBL_458510 (CHEMBL941826) Inhibition of P38 gamma
- ChEMBL_475761 (CHEMBL930277) Inhibition of p38-gamma
- ChEMBL_481048 (CHEMBL997488) Inhibition of PKC gamma
- ChEMBL_489230 (CHEMBL989977) Inhibition of p38beta/gamma
- ChEMBL_509592 (CHEMBL1001353) Inhibition of PI3K gamma
- ChEMBL_582355 (CHEMBL1063392) Inhibition of p38-gamma
- ChEMBL_606945 (CHEMBL1072688) Inhibition of p38-gamma
- ChEMBL_625017 (CHEMBL1109685) Inhibition of p38-gamma
- ChEMBL_627033 (CHEMBL1104515) Inhibition of p38-gamma
- ChEMBL_644879 (CHEMBL1211156) Inhibition of p38-gamma
- ChEMBL_664522 (CHEMBL1259904) Inhibition of PI3K-gamma
- ChEMBL_716959 (CHEMBL1670987) Inhibition of PPAR gamma
- ChEMBL_758493 (CHEMBL1811571) Inhibition of p38-gamma
- ChEMBL_68435 (CHEMBL683047) Binding affinity against Gamma-aminobutyric acid A receptor alpha-6-beta-3-gamma-2
- ChEMBL_70702 (CHEMBL685338) Binding affinity for Gamma-aminobutyric acid A receptor alpha-5-beta-3-gamma-2
- ChEMBL_757720 (CHEMBL1809664) Inhibition of PLK1 assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting
- ChEMBL_2184621 (CHEMBL5096703) Agonist activity to C-terminal domain STING (139 to 379 residues) in human PBMC assessed as IFN-beta secretion
- ChEMBL_2185626 (CHEMBL5097708) Inhibition of cGAS expressed in human THP-1 cells assessed as reduction of IFN-beta expression by ELISA assay
- ChEMBL_2281199 Agonist activity at STING in human THP1-Dual cells assessed as increase in IFN-beta secretion incubated for 24 hrs
- ChEMBL_2354047 Antagonist activity at TLR7 in human Whole blood cell assessed as reduction in IFN-alpha level measured after 30 mins
- ChEMBL_2354048 Antagonist activity at TLR9 in human Whole blood cell assessed as reduction in IFN-alpha level measured after 30 mins
- ChEMBL_302648 (CHEMBL839938) Binding affinity towards gamma-aminobutyric-acid GABA-A receptor alpha-4-beta-3-gamma-2
- ChEMBL_302649 (CHEMBL839939) Binding affinity towards gamma-aminobutyric-acid GABA-A receptor alpha-6-beta-3-gamma-2
- ChEMBL_69813 (CHEMBL678910) Direct activation of human Gamma-aminobutyric acid A receptor alpha-1-beta-2-gamma-2
- ChEMBL_757718 (CHEMBL1809662) Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting
- ChEMBL_196478 (CHEMBL798292) Effective concentration for lipogenesis induced by retinoid X receptor alpha in C3H10T1/2 clone 8 fibroblast cells; Partial agonist
- ChEMBL_2207934 (CHEMBL5120642) Inhibition of JAK1/TYK2 signaling pathway in human primary T-cells assessed as reduction of IFN-alpha induced STAT1 phosphorylation
- ChEMBL_2354033 Antagonist activity at TLR7 in human PBMC cells assessed as reduction in IFN alpha measured after 20 hrs by AlphaLISA assay
- ChEMBL_2354035 Antagonist activity at TLR9 in human PBMC cells assessed as reduction in IFN alpha measured after 20 hrs by AlphaLISA assay
- ChEBML_153125 Inhibition of protein kinase C-gamma
- ChEBML_153154 Inhibition of protein kinase C gamma
- ChEBML_154532 Activity against murine PPAR gamma receptor
- ChEBML_161146 Inhibition of Protein kinase C gamma
- ChEBML_161147 Inhibition of Protein kinase C gamma
- ChEBML_161148 Inhibition of Protein kinase C gamma
- ChEBML_161284 Inhibition of Protein kinase C gamma
- ChEBML_161285 Inhibition of Protein kinase C gamma
- ChEBML_163495 Effective concentration against RAR-gamma receptor
- ChEMBL_1349386 (CHEMBL3269976) Inhibition of human PPAR-gamma
- ChEMBL_1762449 (CHEMBL4197696) Inhibition of human gamma-secretase
- ChEMBL_208172 (CHEMBL819078) Binding affinity against gamma thrombin
- ChEMBL_2267333 Inhibition of p110 gamma (unknown origin)
- ChEMBL_2272293 Inhibition of gamma-secretase (unknown origin)
- ChEMBL_2272599 Inhibition of PI3K gamma (unknown origin)
- ChEMBL_2294027 Inhibition of gamma-secretase (unknown origin)
- ChEMBL_2422156 Agonist activity at human PPAR gamma
- ChEMBL_2517236 Inhibition of p110 gamma (unknown origin)
- ChEMBL_2583445 Inhibition of PI3K gamma (unknown origin)
- ChEMBL_377005 (CHEMBL868560) Inhibition of DNA polymerase gamma
- ChEMBL_463059 (CHEMBL928969) Inhibition of human p38-gamma
- ChEMBL_612859 (CHEMBL1067548) Inhibition of p38-gamma MAPK
- ChEMBL_655504 (CHEMBL1244548) Binding affinity to p38-gamma
- ChEMBL_687469 (CHEMBL1292145) Inhibition of human PKC-gamma
- ChEMBL_773493 (CHEMBL1839859) Inhibition of recombinant p38-gamma
- Inhibition Assay Inhibition assay using gamma-secretase.
- ChEMBL_154354 (CHEMBL880951) Binding affinity towards human peroxisome proliferator activated receptor gamma (PPAR gamma) was determined by HTRF assay
- ChEMBL_70537 (CHEMBL681094) Effective agonist dose for human Gamma-aminobutyric acid A receptor alpha-4-beta-3-gamma-2
- ChEMBL_70714 (CHEMBL682418) Effective agonist dose for human Gamma-aminobutyric acid A receptor alpha-6-beta-3-gamma-2
- ChEMBL_757717 (CHEMBL1809661) Inhibition of MPS1 assessed as [33P]-gamma-ATP incorporation into substrate P38-betatide by gamma counting
- ChEMBL_757719 (CHEMBL1809663) Inhibition of CDK2/Cyclin A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting
- ChEMBL_2452064 Inhibition of PI3K p110-gamma (unknown origin) in presence of [gamma-32P]ATP by radioactivity based kinase assay
- ChEMBL_631390 (CHEMBL1109142) Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631391 (CHEMBL1109143) Inhibition of Plk3 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631403 (CHEMBL1109155) Inhibition of VEGFR3 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631405 (CHEMBL1109157) Inhibition of KIT assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631407 (CHEMBL1109159) Inhibition of AKT1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631408 (CHEMBL1109160) Inhibition of ALK assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631410 (CHEMBL1109162) Inhibition of CDC7 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631411 (CHEMBL1109163) Inhibition of CDK7 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631413 (CHEMBL1111118) Inhibition of CHK1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631415 (CHEMBL1111952) Inhibition of ERK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631416 (CHEMBL1111953) Inhibition of FGFR1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631417 (CHEMBL1111954) Inhibition of IGF1R assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631419 (CHEMBL1111956) Inhibition of IKK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631421 (CHEMBL1111958) Inhibition of LCK assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631422 (CHEMBL1111959) Inhibition of MAPKAPK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631423 (CHEMBL1111960) Inhibition of MET assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631424 (CHEMBL1111961) Inhibition of NEK6 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631426 (CHEMBL1111963) Inhibition of PAK4 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631427 (CHEMBL1111964) Inhibition of PDK1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631430 (CHEMBL1111967) Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631431 (CHEMBL1111968) Inhibition of RET assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631432 (CHEMBL1111969) Inhibition of STK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631434 (CHEMBL1111971) Inhibition of TrkA assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631617 (CHEMBL1106611) Inhibition of VEGFR2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_68433 (CHEMBL683045) Binding affinity for human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-6-beta-3-gamma-2
- ChEMBL_69814 (CHEMBL678911) Potentiation of GABA responses at human Gamma-aminobutyric acid A receptor alpha-1-beta-2-gamma-2
- ChEMBL_70099 (CHEMBL678329) Binding affinity for human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-1-beta-3-gamma-2
- ChEMBL_70261 (CHEMBL681248) Binding affinity to human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-2-beta-3-gamma-2
- ChEMBL_70416 (CHEMBL682251) Binding affinity for human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-3-beta-3-gamma-2
- ChEMBL_70695 (CHEMBL681480) Binding affinity for human recombinant gamma-aminobutyric-acid (GABA) A receptor alpha-5-beta-3-gamma-2
- ChEMBL_745831 (CHEMBL1776201) Inhibition of NEK6 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745832 (CHEMBL1776202) Inhibition of NIM1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745833 (CHEMBL1776203) Inhibition of P38alpha assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745834 (CHEMBL1776204) Inhibition of PAK4 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745836 (CHEMBL1776206) Inhibition of PDK1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745837 (CHEMBL1776207) Inhibition of EphA2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745838 (CHEMBL1776208) Inhibition of ERK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745839 (CHEMBL1776209) Inhibition of FAK assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745840 (CHEMBL1776210) Inhibition of FGFR1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745842 (CHEMBL1776212) Inhibition of Haspin assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745843 (CHEMBL1776213) Inhibition of IGFR1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745844 (CHEMBL1776214) Inhibition of IKK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745845 (CHEMBL1776215) Inhibition of IR assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745846 (CHEMBL1776216) Inhibition of JAK1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745847 (CHEMBL1776217) Inhibition of JAK3 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745848 (CHEMBL1776218) Inhibition of KIT assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745849 (CHEMBL1776219) Inhibition of LCK assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745850 (CHEMBL1776220) Inhibition of LYN assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745851 (CHEMBL1776221) Inhibition of MAPKAPK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745852 (CHEMBL1776222) Inhibition of MET assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745853 (CHEMBL1776223) Inhibition of MNK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745854 (CHEMBL1776224) Inhibition of MPS1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745855 (CHEMBL1776225) Inhibition of MST4 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745933 (CHEMBL1776303) Inhibition of PERK assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745934 (CHEMBL1776304) Inhibition of PIM1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745935 (CHEMBL1776305) Inhibition of PIM2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745936 (CHEMBL1776306) Inhibition of PKAalpha assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745937 (CHEMBL1776307) Inhibition of PKCbeta assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745938 (CHEMBL1776308) Inhibition of RET assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745939 (CHEMBL1776309) Inhibition of ROS1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745941 (CHEMBL1775240) Inhibition of Syk assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745942 (CHEMBL1775241) Inhibition of TLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745943 (CHEMBL1775242) Inhibition of TRKA assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745944 (CHEMBL1775243) Inhibition of TYK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745945 (CHEMBL1775244) Inhibition of VEGFR2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745946 (CHEMBL1775245) Inhibition of VEGFR3 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745947 (CHEMBL1775246) Inhibition of ZAP70 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747145 (CHEMBL1777511) Inhibition of PLK1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747146 (CHEMBL1777512) Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747147 (CHEMBL1777513) Inhibition of PLK3 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747248 (CHEMBL1776507) Inhibition of FLT3 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747249 (CHEMBL1776508) Inhibition of MELK assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747251 (CHEMBL1776510) Inhibition of ABL assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747252 (CHEMBL1776511) Inhibition of ACK1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747253 (CHEMBL1776512) Inhibition of AKT1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747254 (CHEMBL1776513) Inhibition of ALK assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747257 (CHEMBL1776516) Inhibition of BRK assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747258 (CHEMBL1776517) Inhibition of BUB1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747265 (CHEMBL1776524) Inhibition of CHK1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747266 (CHEMBL1776525) Inhibition of EEF2K assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_1684603 (CHEMBL4035082) Antagonist activity at TLR9 in human PBMC assessed as inhibition of CpGA-induced IFN-alpha production after 18 hrs by ELISA
- ChEMBL_2184622 (CHEMBL5096704) Agonist activity to C-terminal domain STING HAQ mutant (139 to 379 residues) in human PBMC assessed as IFN-beta secretion
- ChEMBL_2354049 Antagonist activity at TLR7 in mouse Splenocyte assessed as reduction in IFN-alpha level measured after 20 hrs by Spectramax M5 method
- ChEMBL_2354050 Antagonist activity at TLR9 in mouse Splenocyte assessed as reduction in IFN-alpha level measured after 20 hrs by Spectramax M5 method
- ChEBML_147141 Binding affinity for gamma-S binding assay
- ChEBML_161272 Inhibition of human Protein kinase C gamma
- ChEBML_161274 Inhibition of human Protein kinase C gamma
- ChEBML_196013 Binding affinity towards Retinoic acid receptor gamma
- ChEBML_196319 Binding affinity against Retinoic acid receptor gamma
- ChEBML_196322 Binding affinity for Retinoic acid receptor gamma
- ChEBML_196329 Binding affinity against Retinoic acid receptor gamma
- ChEBML_306114 In vitro binding affinity for PPAR-gamma
- ChEBML_68902 Inhibitory concentration against gamma-secretase was determined
- ChEMBL_1365495 (CHEMBL3297010) Inhibition of human DNA polymerase gamma
- ChEMBL_1450781 (CHEMBL3363926) Inhibition of PI3K-gamma (unknown origin)
- ChEMBL_153124 (CHEMBL758470) Inhibition of protein kinase C gamma
- ChEMBL_153154 (CHEMBL761877) Inhibition of protein kinase C gamma
- ChEMBL_154187 (CHEMBL762736) Transcriptional activation by human PPAR gamma
- ChEMBL_154211 (CHEMBL759456) Inhibitory concentration of the PPAR gamma)
- ChEMBL_1583672 (CHEMBL3815759) Inhibition of PI3K gamma (unknown origin)
- ChEMBL_161143 (CHEMBL767411) Inhibition of protein kinase C gamma
- ChEMBL_161145 (CHEMBL767413) Inhibition of Protein kinase C gamma
- ChEMBL_161146 (CHEMBL767414) Inhibition of Protein kinase C gamma
- ChEMBL_161284 (CHEMBL766914) Inhibition of Protein kinase C gamma
- ChEMBL_163481 (CHEMBL772394) Transcriptional activation for RAR gamma receptor
- ChEMBL_1762453 (CHEMBL4197700) Inhibition of gamma-secretase (unknown origin)
- ChEMBL_1925267 (CHEMBL4428339) Inhibition of gamma secretase (unknown origin)
- ChEMBL_2026875 (CHEMBL4681033) Agonist activity at human PPAR-gamma
- ChEMBL_2199021 (CHEMBL5111537) Inhibition of human DNA polymerase gamma
- ChEMBL_220901 (CHEMBL824656) Binding affinity at human PPAR gamma
- ChEMBL_339276 (CHEMBL867229) Binding affinity to human PPAR gamma
- ChEMBL_424080 (CHEMBL855083) Displacement of Fluormone from PPAR gamma
- ChEMBL_473713 (CHEMBL939369) Inhibition of p38-gamma MAP kinase
- ChEMBL_476359 (CHEMBL921519) Binding affinity at PPAR gamma receptor
- ChEMBL_533421 (CHEMBL983382) Inhibition of human DNA polymerase gamma
- ChEMBL_537070 (CHEMBL986219) Binding affinity to human p38-gamma
- ChEMBL_68895 (CHEMBL678617) Inhibition of human gamma-secretase activity
- ChEMBL_68900 (CHEMBL676871) In vitro inhibition of gamma secretase.
- ChEMBL_720298 (CHEMBL1679164) Inhibition of human DNA polymerase gamma
- ChEMBL_941101 (CHEMBL2330898) Inhibition of PKC gamma (unknown origin)
- ChEMBL_154377 (CHEMBL758986) in vitro agonist activity against peroxisome proliferator activated receptor-gamma (PPAR-gamma), using alkaline phosphatase activity transactivator assay
- ChEMBL_558101 (CHEMBL956591) Displacement of [3H]GHB from gamma-hydroxybutyrate binding site of gamma-hydroxybutyrate receptor in rat forebrain synaptic membranes
- ChEMBL_631394 (CHEMBL1109146) Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631401 (CHEMBL1109153) Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631406 (CHEMBL1109158) Inhibition of c-ABL assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631409 (CHEMBL1109161) Inhibition of Aurora B assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631418 (CHEMBL1111955) Inhibition of GSK3-beta assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631420 (CHEMBL1111957) Inhibition of insulin receptor assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631428 (CHEMBL1111965) Inhibition of PKA-alpha assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631429 (CHEMBL1111966) Inhibition of PKC-beta assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_745841 (CHEMBL1776211) Inhibition of GSK3-beta assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747255 (CHEMBL1776514) Inhibition of Aur-A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747256 (CHEMBL1776515) Inhibition of Aur-B assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747259 (CHEMBL1776518) Inhibition of CDC7/DBF4 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747260 (CHEMBL1776519) Inhibition of CDK1/CYCB assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747261 (CHEMBL1776520) Inhibition of CDK2/CYCA assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747262 (CHEMBL1776521) Inhibition of CDK2/CYCE assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747263 (CHEMBL1776522) Inhibition of CDK4/CYCD1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_747264 (CHEMBL1776523) Inhibition of CDK5/P25 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_306707 (CHEMBL832609) Inhibition of [3H]9-cis-retinoic acid binding to human retinoid X receptor alpha ligand-binding domain expressed in Escherichia coli
- ChEBML_1684604 Antagonist activity at TLR9 in human plasmacytoid dendritic cells assessed as inhibition of CpGA-induced IFN-alpha production after 18 hrs by ELISA
- ChEMBL_2184606 (CHEMBL5096688) Agonist activity at STING in human L929 cells assessed as IFN-beta RNA level measured after 4 hrs by qRT-PCR analysis
- ChEMBL_2322395 Activation of STING signalling pathway in human PBMC cells assessed as increase in IFN-beta level incubated for 4 hrs by ELISA method
- ChEMBL_2354052 Antagonist activity at TLR7 in mouse Whole blood cell assessed as reduction in IFN-alpha level measured after 20 hrs by AlphaLISA method
- ChEMBL_2354053 Antagonist activity at TLR9 in mouse Whole blood cell assessed as reduction in IFN-alpha level measured after 20 hrs by AlphaLISA method
- ChEMBL_631393 (CHEMBL1109145) Inhibition of CDK2/Cyclin A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631400 (CHEMBL1109152) Inhibition of CDK1/Cyclin B assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631402 (CHEMBL1109154) Inhibition of CDK2/Cyclin E assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631412 (CHEMBL1111117) Inhibition of CDK4/Cyclin D1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_631414 (CHEMBL1111951) Inhibition of EGFR isoform 1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting
- ChEMBL_68434 (CHEMBL683046) Binding affinity measured using LtK- cell membranes expressing Gamma-aminobutyric acid A receptor alpha-6-beta-3-gamma-2
- ChEMBL_70256 (CHEMBL682715) Agonist activity on human Gamma-aminobutyric acid A receptor alpha-2-beta-3-gamma-2 expressed in Xenopus oocytes
- ChEMBL_70411 (CHEMBL682825) Agonist activity on human Gamma-aminobutyric acid A receptor alpha-3-beta-3-gamma-2 expressed in Xenopus oocytes
- ChEMBL_70701 (CHEMBL685337) Binding affinity measured using LtK- cell membranes expressing Gamma-aminobutyric acid A receptor alpha-5-beta-3-gamma-2
- ChEBML_196498 Compound was tested for functional activity in CV-1 cells transfected with an expression vector for retinoid X receptor alpha using transactivation assay
- ChEMBL_1684604 (CHEMBL4035083) Antagonist activity at TLR9 in human plasmacytoid dendritic cells assessed as inhibition of CpGA-induced IFN-alpha production after 18 hrs by ELISA
- ChEMBL_1989204 (CHEMBL4622751) Antagonist activity at TLR9 in human pDC assessed as inhibition of ODN2216-induced IFN-alpha production incubated for 24 hrs measured by ELISA
- ChEMBL_2198049 (CHEMBL5110565) Agonist activity at STING in human THP-1 cells assessed as increase in IFN-beta secretion incubated for 5 hrs by AlphaLISA assay
- ChEBML_139553 Activation of murine PPAR gamma ligand binding domain
- ChEBML_153232 Maximum transcriptional activation of human PPAR gamma receptor
- ChEBML_196016 Binding affinity towards human Retinoic acid receptor gamma
- ChEBML_196170 Transcriptional activation of retinoic acid receptor RAR gamma
- ChEBML_70524 Binding affinity for retinoic acid receptor RAR gamma
- ChEBML_70528 Binding affinity for retinoic acid receptor RAR gamma
- ChEMBL_1442318 (CHEMBL3377679) Binding affinity to PPAR-gamma (unknown origin)
- ChEMBL_153629 (CHEMBL762525) In vitro transcriptional activation by PPAR gamma
- ChEMBL_153632 (CHEMBL762528) In vitro transcriptional activation by PPAR gamma
- ChEMBL_153634 (CHEMBL762530) Final binding affinity against PPAR-gamma receptor
- ChEMBL_153635 (CHEMBL762531) Initial binding affinity against PPAR-gamma receptor
- ChEMBL_161274 (CHEMBL772955) Inhibition of human Protein kinase C gamma
- ChEMBL_161278 (CHEMBL772959) Inhibition of Protein kinase C gamma (PKC)
- ChEMBL_1721611 (CHEMBL4136611) Inhibition of cystathionine gamma-lyase (unknown origin)
- ChEMBL_195999 (CHEMBL800488) Binding affinity for Retinoic acid receptor gamma
- ChEMBL_196001 (CHEMBL800490) Binding affinity for Retinoic acid receptor gamma
- ChEMBL_196006 (CHEMBL797870) Agonistic activity towards retinoic acid receptor-gamma
- ChEMBL_196007 (CHEMBL797871) Antagonistic activity towards retinoic acid receptor-gamma
- ChEMBL_196015 (CHEMBL798025) Selective activity towards retinoic acid receptor-gamma
- ChEMBL_196308 (CHEMBL805023) Transactivation potency for Retinoic acid receptor gamma
- ChEMBL_196322 (CHEMBL806265) Binding affinity for Retinoic acid receptor gamma
- ChEMBL_306114 (CHEMBL830065) In vitro binding affinity for PPAR-gamma
- ChEMBL_320732 (CHEMBL880877) Dissociation constant for Retinoic acid receptor gamma
- ChEMBL_439784 (CHEMBL888894) Displacement of [3H]rosiglitazone from PPAR gamma
- ChEMBL_531813 (CHEMBL991525) Antagonist activity at protein kinase C gamma
- ChEMBL_543160 (CHEMBL1014320) Inhibition of gamma-glutamyltranspeptidase by colorimetric assay
- ChEMBL_586604 (CHEMBL1061183) Binding constant for full-length p38-gamma
- ChEMBL_774246 (CHEMBL1908463) Binding constant for p38-gamma kinase domain
- ChEMBL_978823 (CHEMBL2423425) Inhibition of PI-3K gamma (unknown origin)
- ChEMBL_434338 (CHEMBL919396) Agonist activity at human opioid gamma receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding
- ChEMBL_70095 (CHEMBL678325) Effective agonist dose for human Gamma-aminobutyric acid A receptor alpha-1-beta-3-gamma-2 expressed in Xenopus oocytes
- ChEMBL_70691 (CHEMBL679474) Effective agonist dose for human Gamma-aminobutyric acid A receptor alpha-5-beta-3-gamma-2 expressed in Xenopus oocytes
- ChEMBL_196498 (CHEMBL798312) Compound was tested for functional activity in CV-1 cells transfected with an expression vector for retinoid X receptor alpha using transactivation assay
- ChEMBL_196634 (CHEMBL798187) Compound was tested for functional activity in CV-1 cells transfected with an expression vector for retinoid X receptor beta using transactivation assay
- ChEMBL_1831743 (CHEMBL4331751) Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFN-alpha stimulated TYK2 phosphorylation by caspase3/7 reagent-based Western blot analysis
- ChEMBL_1831744 (CHEMBL4331752) Inhibition of JAK1 in human Jurkat cells assessed as reduction in IFN-alpha stimulated JAK1 phosphorylation by caspase3/7 reagent-based Western blot analysis
- ChEMBL_1831745 (CHEMBL4331753) Inhibition of JAK2 in human Jurkat cells assessed as reduction in IFN-alpha stimulated JAK2 phosphorylation by caspase3/7 reagent-based Western blot analysis
- ChEMBL_1831746 (CHEMBL4331754) Inhibition of JAK3 in human Jurkat cells assessed as reduction in IFN-alpha stimulated JAK3 phosphorylation by caspase3/7 reagent-based Western blot analysis
- ChEMBL_70090 (CHEMBL677036) Inhibition of [3H]-Ro- 15-1788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-1-beta-3-gamma-2
- ChEMBL_70252 (CHEMBL682711) Inhibition of [3H]-Ro- 15-1788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-2-beta-3-gamma-2
- ChEMBL_70257 (CHEMBL681244) Effective dose for agonist activity on human Gamma-aminobutyric acid A receptor alpha-2-beta-3-gamma-2 in Xenopus oocytes
- ChEMBL_70407 (CHEMBL680434) Inhibition of [3H]-Ro- 15-1788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-3-beta-3-gamma-2
- ChEMBL_70552 (CHEMBL680671) Inhibition of [3H]-Ro- 15-1788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-5-beta-3-gamma-2
- ChEBML_196637 Compound was tested for binding affinity against retinoid X receptor using 5 nM of [3H]9-cis-RA as a radioligand in baculovirus expressed receptor
- ChEBML_161307 Binding affinity for protein kinase C gamma-C1B domain
- ChEBML_196331 Inhibition of [3H]ATRA binding to RAR gamma receptor
- ChEBML_221639 Inhibition of p56 lck autophosphorylation, gamma-[33P]ATP incorporation
- ChEMBL_147142 (CHEMBL754174) Binding affinity for gamma-S binding assay; Inactive
- ChEMBL_153232 (CHEMBL764465) Maximum transcriptional activation of human PPAR gamma receptor
- ChEMBL_154518 (CHEMBL764404) Transcriptional activation of peroxisome proliferator activated receptor gamma
- ChEMBL_154539 (CHEMBL760259) Binding affinity for peroxisome proliferator activated receptor gamma
- ChEMBL_1563455 (CHEMBL3783048) Agonist activity at PPAR-gamma receptor (unknown origin)
- ChEMBL_195987 (CHEMBL807693) Transcriptional activation of Retinoic acid receptor RAR gamma
- ChEMBL_195988 (CHEMBL879244) Transcriptional activation of Retinoic acid receptor RAR gamma
- ChEMBL_196157 (CHEMBL804930) Transcriptional activation of Retinoic acid receptor RAR gamma
- ChEMBL_196160 (CHEMBL804933) Transcriptional activation of Retinoic acid receptor RAR gamma
- ChEMBL_196170 (CHEMBL804943) Transcriptional activation of retinoic acid receptor RAR gamma
- ChEMBL_196178 (CHEMBL804951) Transcriptional activation of Retinoic acid receptor RAR gamma
- ChEMBL_196667 (CHEMBL803399) Transcriptional activation of Retinoic acid receptor RAR gamma
- ChEMBL_197234 (CHEMBL801380) Effective concentrations against Retinoic acid receptor RXR-gamma
- ChEMBL_197243 (CHEMBL803365) Binding affinity towards Retinoic acid receptor RXR-gamma
- ChEMBL_2267394 Inhibition of human gamma secretase by western blot assay
- ChEMBL_2494610 Agonist activity at full length ERR-gamma (unknown origin)
- ChEMBL_2521088 Inhibition of peroxisome proliferator-activated receptors gamma (unknown origin)
- ChEMBL_305937 (CHEMBL833484) Inhibition of human Peroxisome proliferator activated receptor gamma
- ChEMBL_306190 (CHEMBL830984) In vitro binding affinity for human PPAR gamma
- ChEMBL_320735 (CHEMBL881208) Binding affinity towards peroxisome proliferator activated receptor gamma
- ChEMBL_339279 (CHEMBL868414) Transactivation by human PPAR gamma in COS1 cells
- ChEMBL_643027 (CHEMBL1176541) Binding affinity to human NTR1 by gamma counting
- ChEMBL_643028 (CHEMBL1176542) Binding affinity to human NTR2 by gamma counting
- ChEMBL_68428 (CHEMBL682874) Inhibition of Gamma-aminobutyric acid type B receptor
- ChEMBL_70524 (CHEMBL681081) Binding affinity for retinoic acid receptor RAR gamma
- ChEMBL_70649 (CHEMBL678640) Binding affinity against Gamma-amino-N-butyrate transaminase
- ChEMBL_70659 (CHEMBL678649) Inhibitory activity against Gamma-amino-N-butyrate transaminase
- ChEMBL_951390 (CHEMBL2349764) Inhibition of human FAK using [gamma-33P]ATP
- ChEMBL_2322376 Activation of STING signalling pathway in human wild type THP-1 cells assessed as increase in IFN-beta secretion incubated for 4 hrs by ELISA method